View Inc. - Ordinary Shares (VIEW) 10-Q 14 Nov 23 2023 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2023	Nov. 09, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-39470
Entity Registrant Name	VIEW, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	84-3235065
Entity Address, Address Line One	195 South Milpitas Blvd
Entity Address, City or Town	Milpitas
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95035
City Area Code	408
Local Phone Number	263-9200
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		4,067,035
Amendment Flag	false
Entity Central Index Key	0001811856
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Class A common stock, par value, $0.0001 per share
Document Information [Line Items]
Title of 12(b) Security	Class A common stock, par value, $0.0001 per share
Trading Symbol	VIEW
Security Exchange Name	NASDAQ
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $690.00
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $690.00
Trading Symbol	VIEWW
Security Exchange Name	NASDAQ

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (unaudited) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 50,618,000	$ 95,858,000
Short-term investments	0	102,284,000
Accounts receivable, net of allowances	42,571,000	42,407,000
Current contract assets	20,384,000	14,587,000
Inventories	16,699,000	17,373,000
Short-term restricted cash	14,000,000	1,859,000
Prepaid expenses and other current assets	14,560,000	21,851,000
Total current assets	158,832,000	296,219,000
Property and equipment, net	81,462,000	262,360,000
Restricted cash	726,000	16,448,000
Right-of-use assets	18,957,000	18,485,000
Note receivable	6,000,000	6,999,000
Other assets	25,461,000	18,515,000
Total assets	291,438,000	619,026,000
Current liabilities:
Accounts payable	10,232,000	21,099,000
Accrued expenses and other current liabilities	57,209,000	72,410,000
Accrued compensation	8,544,000	9,799,000
Deferred revenue	11,284,000	9,199,000
Total current liabilities	87,269,000	112,507,000
Debt, non-current	208,331,000	218,837,000
Sponsor earn-out liability	0	506,000
Lease liabilities	19,329,000	19,589,000
Warranty liability	26,989,000	29,337,000
Other liabilities	17,458,000	17,758,000
Total liabilities	359,376,000	398,534,000
Commitments and contingencies
Stockholders’ equity:
Common stock, $0.0001 par value; 600,000,000 shares authorized as of September 30, 2023 and December 31, 2022; 4,053,580 and 3,695,598 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	0	0
Additional paid-in capital	2,863,177,000	2,814,912,000
Accumulated deficit	(2,931,115,000)	(2,594,420,000)
Total stockholders’ equity	(67,938,000)	220,492,000
Total liabilities and stockholders’ equity	291,438,000	619,026,000
Nonrelated Party
Current liabilities:
Debt, non-current	94,722,000	109,754,000
Related Party
Current liabilities:
Debt, non-current	$ 113,609,000	$ 109,083,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)	Jul. 26, 2023	Sep. 30, 2023 $ / shares shares	Dec. 31, 2022 $ / shares shares	Oct. 26, 2022 $ / shares	Mar. 09, 2021 $ / shares shares
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)		600,000,000	600,000,000		600,000,000
Common stock, shares issued (in shares)		4,053,580	3,695,598
Common stock, share outstanding (in shares)		4,053,580	3,695,598
Reverse stock split, conversion ratio	0.0167

Condensed Consolidated Statemen

Condensed Consolidated Statements of Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenue	$ 38,220	$ 23,762	$ 84,602	$ 57,090
Cost of revenue	42,573	49,126	124,596	129,219
Gross loss	(4,353)	(25,364)	(39,994)	(72,129)
Operating expenses:
Research and development	8,918	15,554	31,573	56,157
Selling, general, and administrative	25,518	41,174	74,429	124,888
Impairment of long-lived assets	170,300	0	174,300	0
Restructuring costs (Note 11)	(662)	0	4,845	0
Total operating expenses	204,074	56,728	285,147	181,045
Loss from operations	(208,427)	(82,092)	(325,141)	(253,174)
Interest and other expense (income), net:
Interest expense, net	4,399	58	11,530	324
Other expense, net	158	118	439	259
Gain on fair value change, net	0	(226)	(513)	(6,511)
Interest and other expense (income), net	4,557	(50)	11,456	(5,928)
Loss before provision for income taxes	(212,984)	(82,042)	(336,597)	(247,246)
Provision for income taxes	62	23	98	77
Net loss	(213,046)	(82,065)	(336,695)	(247,323)
Comprehensive loss	$ (213,046)	$ (82,065)	$ (336,695)	$ (247,323)
Net loss per share, basic (in shares)	$ (53.06)	$ (22.93)	$ (84.54)	$ (69.21)
Net loss per share, diluted (in shares)	$ (53.06)	$ (22.93)	$ (84.54)	$ (69.21)
Weighted-average shares used in calculation of net loss per share, basic (in dollars per share)	4,015,307	3,579,584	3,982,824	3,573,700
Weighted-average shares used in calculation of net loss per share, diluted (in dollars per share)	4,015,307	3,579,584	3,982,824	3,573,700
Nonrelated Party
Revenue	$ 26,469	$ 22,368	$ 65,427	$ 52,156
Cost of revenue	31,481	49,099	105,899	128,959
Related Party
Revenue	11,751	1,394	19,175	4,934
Cost of revenue	$ 11,092	$ 27	$ 18,697	$ 260

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (unaudited) (Parenthetical)	Jul. 26, 2023
Income Statement [Abstract]
Reverse stock split, conversion ratio	0.0167

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders’ Equity (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		3,653,000
Beginning balance at Dec. 31, 2021	$ 479,338		$ 2,736,669	$ (2,257,331)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units (in shares)		1,000
Stock-based compensation	17,468		17,468
Net loss	(82,372)			(82,372)
Ending balance (in shares) at Mar. 31, 2022		3,654,000
Ending balance at Mar. 31, 2022	414,434		2,754,137	(2,339,703)
Beginning balance (in shares) at Dec. 31, 2021		3,653,000
Beginning balance at Dec. 31, 2021	479,338		2,736,669	(2,257,331)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares withheld related to net share settlement of equity awards	(3,100)
Net loss	(247,323)
Ending balance (in shares) at Sep. 30, 2022		3,691,000
Ending balance at Sep. 30, 2022	287,774	$ 0	2,792,428	(2,504,654)
Beginning balance (in shares) at Mar. 31, 2022		3,654,000
Beginning balance at Mar. 31, 2022	414,434		2,754,137	(2,339,703)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	18,141		18,141
Net loss	(82,886)			(82,886)
Ending balance (in shares) at Jun. 30, 2022		3,654,000
Ending balance at Jun. 30, 2022	349,689		2,772,278	(2,422,589)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units (in shares)		68,000
Shares withheld related to net share settlement of equity awards (in shares)		(31,000)
Shares withheld related to net share settlement of equity awards	(3,076)		(3,076)
Stock-based compensation	23,226		23,226
Net loss	(82,065)			(82,065)
Ending balance (in shares) at Sep. 30, 2022		3,691,000
Ending balance at Sep. 30, 2022	$ 287,774	$ 0	2,792,428	(2,504,654)
Beginning balance (in shares) at Dec. 31, 2022	3,695,598	3,696,000
Beginning balance at Dec. 31, 2022	$ 220,492		2,814,912	(2,594,420)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units (in shares)		58,000
Shares withheld related to net share settlement of equity awards (in shares)		(22,000)
Shares withheld related to net share settlement of equity awards	(1,001)		(1,001)
Shares issued upon Convertible Notes Conversion (in shares)		280,000
Shares issued upon Convertible Notes conversion	17,828		17,828
Stock-based compensation	10,962		10,962
Net loss	(67,289)			(67,289)
Ending balance (in shares) at Mar. 31, 2023		4,012,000
Ending balance at Mar. 31, 2023	$ 180,992		2,842,701	(2,661,709)
Beginning balance (in shares) at Dec. 31, 2022	3,695,598	3,696,000
Beginning balance at Dec. 31, 2022	$ 220,492		2,814,912	(2,594,420)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares withheld related to net share settlement of equity awards (in shares)	(49,389)
Shares withheld related to net share settlement of equity awards	$ (1,400)
Vesting of restricted stock units (in shares)	0
Net loss	$ (336,695)
Ending balance (in shares) at Sep. 30, 2023	4,053,580	4,054,000
Ending balance at Sep. 30, 2023	$ (67,938)	$ 0	2,863,177	(2,931,115)
Beginning balance (in shares) at Mar. 31, 2023		4,012,000
Beginning balance at Mar. 31, 2023	180,992		2,842,701	(2,661,709)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units (in shares)		34,000
Shares withheld related to net share settlement of equity awards (in shares)		(13,000)
Shares withheld related to net share settlement of equity awards	(293)		(293)
Stock-based compensation	10,530		10,530
Net loss	(56,360)			(56,360)
Ending balance (in shares) at Jun. 30, 2023		4,033,000
Ending balance at Jun. 30, 2023	$ 134,869		2,852,938	(2,718,069)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units (in shares)		35,000
Shares withheld related to net share settlement of equity awards (in shares)	(14,035)	(14,000)
Shares withheld related to net share settlement of equity awards	$ (142)		(142)
Stock-based compensation	10,381		10,381
Net loss	$ (213,046)			(213,046)
Ending balance (in shares) at Sep. 30, 2023	4,053,580	4,054,000
Ending balance at Sep. 30, 2023	$ (67,938)	$ 0	$ 2,863,177	$ (2,931,115)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Stockholders’ Equity (unaudited) (Parenthetical)	Jul. 26, 2023
Statement of Stockholders' Equity [Abstract]
Reverse stock split, conversion ratio	0.0167

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (336,695)	$ (247,323)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	16,472	17,797
Gain on fair value change, net	(513)	(6,511)
Stock-based compensation	32,562	58,835
Non-cash interest expense	14,126	0
Impairment of long-lived assets	174,300	0
Other	2,639	1,008
Changes in operating assets and liabilities:
Accounts receivable	(890)	6,693
Inventories	674	(7,585)
Prepaid expenses and other current assets	(1,864)	(11,090)
Other assets	(10,576)	2,616
Accounts payable	(7,131)	(2,803)
Deferred revenue	2,084	(3,783)
Accrued compensation	(1,255)	1,922
Accrued expenses and other liabilities	(23,536)	(13,977)
Net cash used in operating activities	(139,603)	(204,201)
Cash flows from investing activities:
Purchases of property and equipment	(7,510)	(14,396)
Purchases of short-term investments	(106,032)	0
Maturities of short-term investments	210,133	0
Disbursement under loan receivable (Note 4)	(3,001)	(5,160)
Net cash provided by (used in) investing activities	93,590	(19,556)
Cash flows from financing activities:
Payment of debt issuance costs (Note 7)	(228)	0
Repayment of other debt obligations	(735)	(735)
Payments of obligations under finance leases	(409)	(400)
Taxes paid related to the net share settlement of equity awards (Note 8)	(1,436)	(3,076)
Net cash used in financing activities	(2,808)	(4,211)
Net decrease in cash, cash equivalents, and restricted cash	(48,821)	(227,968)
Cash, cash equivalents, and restricted cash, beginning of period	114,165	297,543
Cash, cash equivalents, and restricted cash, end of period	65,344	69,575
Supplemental disclosure of cash flow information:
Cash paid for interest	155	55
Non-cash investing and financing activities:
Payables and accrued liabilities related to purchases of property and equipment	265	1,569
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	2,624	0
Common stock issued upon vesting of restricted stock units	3,513	6,651
Common stock issued upon conversion of Convertible Notes	$ 18,000	$ 0

Organization and Summary of Sig

Organization and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Summary of Significant Accounting Policies	Organization and Summary of Significant Accounting Policies Organization View, Inc. and its wholly-owned subsidiaries (collectively “View” or the “Company”), headquartered in Milpitas, California, is a technology company that manufactures smart building products intended to help improve people’s health, productivity, and experience, while simultaneously reducing energy consumption. View’s primary product is a proprietary electrochromic or “smart” glass panel that when combined with View’s proprietary network infrastructure and software, intelligently adjusts in response to the sun by tinting from clear to dark states, and vice versa, thereby reducing heat and glare. The Company is devoting substantially all of its efforts towards the manufacturing, sale and further development of its product platforms, and marketing of both custom and standardized product solutions. Basis of Presentation The condensed consolidated financial statements and accompanying notes have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and regulations of the U.S. Securities and Exchange Commission (the “SEC”) for interim financial reporting and are unaudited. The Company’s condensed consolidated financial statements include the accounts of View, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company’s fiscal year ends on December 31. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2022, included in the Company’s 2022 Annual Report on Form 10-K filed with the SEC on March 31, 2023. The information as of December 31, 2022 included in the condensed consolidated balance sheets was derived from those audited consolidated financial statements. For the three and nine months ended September 30, 2023 and 2022, there was no difference between net loss and total comprehensive loss. The condensed consolidated financial statements were prepared on the same basis as the audited consolidated financial statements and included herein reflect all adjustments, including normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of the Company’s financial position as of September 30, 2023, the results of operations for the three and nine months ended September 30, 2023 and the cash flows for the nine months ended September 30, 2023. The results of operations for the three and nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected for the full year or any other future interim or annual periods. All amounts are presented in U.S. dollars ($). Liquidity and Going Concern Since inception, the Company has not achieved profitable operations or positive cash flows from operations. The Company’s accumulated deficit totaled $2,931.1 million as of September 30, 2023. For the nine months ended September 30, 2023, the Company had a net loss of approximately $336.7 million and negative cash flows from operations of approximately $139.6 million. In addition, for the nine months ended September 30, 2022, the Company had a net loss of approximately $247.3 million and negative cash flows from operations of approximately $204.2 million. Cash and cash equivalents were $50.6 million as of September 30, 2023. In accordance with Accounting Standards Codification (“ASC”) Topic 205-40, Going Concern, the Company evaluates whether there are certain conditions and events, considered in the aggregate, which raise substantial doubt about the Company’s ability to continue as a going concern. As further detailed below, the Company has concluded that there is substantial doubt about its ability to continue as a going concern as the Company estimates that its existing financial resources are only adequate to fund its forecasted operating costs and meet its obligations into, but not beyond the first quarter of 2024. This projection is based on the Company’s current expectations regarding revenues, collections, cost structure, current cash burn rate, initial net proceeds of approximately $10 million and anticipated additional draws of $37.5 million from the Credit Agreement disclosed further in Note 15 , and other operating assumptions. The Company’s ability to make the anticipated additional draws are subject to (i) a cap on the amount of draws that may be requested in any one calendar week of $2 million, (ii) with respect to any draw made after December 31, 2023, delivery of a budget approved by the lenders, (iii) no default or event of default continuing under the Credit Agreement, (iv) the representations and warranties set forth in the Credit Agreement and the related loan documentation being true and correct in all material respects, (v) the use of proceeds of any such draw not being in contravention with the then- current approved budget, (vi) the consummation of certain required post-closing requirements and (vii) liquidity of at least $25 million. If the Company is not able to secure sufficient financing and the audited financial statements for the fiscal year ending December 31, 2023 include a “going concern” qualification, this will result in an event of default under the Credit Agreement. Should an event of default occur, any available borrowings from the Credit Agreement would no longer be available and outstanding indebtedness under the Credit Agreement may become immediately due and payable. To address its cash needs, the Company continues to seek additional sources of capital, although, to date, additional sources of capital have not been identified. As there can be no assurance that such necessary financing will be available, the Company may be required to execute other strategic alternatives to maximize stakeholder value, including further expense reductions, sale of all or portions of the business, corporate capital restructuring or formal reorganization, or liquidation of assets. The Company has historically financed its operations through revenue generation from product sales, the issuance and sale of redeemable convertible preferred stock, the issuance of debt financing, and the gross proceeds associated with the contribution of cash and the issuance of private investment in public equity (“PIPE”) in connection with the Company’s merger completed on March 8, 2021. There can be no assurance that the necessary additional financing will be available on terms acceptable to the Company, or at all. If the Company raises funds in the future by issuing equity securities, dilution to stockholders will occur and may be substantial. Any equity securities issued may also provide for rights, preferences, or privileges senior to those of holders of common stock. If the Company raises funds in the future by issuing additional debt securities, these debt securities could have rights, preferences, and privileges senior to those of preferred and common stockholders. The terms of any additional debt securities or borrowings could impose significant restrictions on the Company’s operations. The capital markets have experienced in the past, and may experience in the future, periods of upheaval that could impact the availability and cost of equity and debt financing. In addition, recent and anticipated future increases in federal fund rates set by the Federal Reserve, which serve as a benchmark for rates on borrowing, will continue to impact the cost of debt financing. In order to reduce the cash used in operating activities, the Company implemented certain cost savings initiatives in the second half of 2022 and a restructuring plan in March 2023 as further discussed in Note 11 , as well as additional restructuring activities in October 2023 as further discussed in Note 15 . While these plans are anticipated to reduce cash outflow when compared to prior periods, the Company’s continued existence is dependent upon its ability to obtain additional financing, as well as to attain and maintain profitable operations by entering into profitable sales contracts and generating sufficient cash flow to meet its obligations on a timely basis. The Company’s business will require a significant amount of capital investment to execute its long-term business plans. The accompanying condensed consolidated financial statements have been prepared on the basis that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern. Summary of Significant Accounting Policies There have been no significant changes to the significant accounting policies disclosed in Note 1 of the audited consolidated financial statements as of and for the year ended December 31, 2022 included in the Company’s 2022 Annual Report on Form 10-K filed with the SEC on March 31, 2023. Concentration of Credit Risk and Other Risks and Uncertainties Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash and cash equivalents, restricted cash, and accounts receivable. Cash and cash equivalents are almost entirely held by domestic financial institutions with high credit standings. Such deposits may, at times, exceed federally insured limits. As of September 30, 2023, the Company has not experienced any losses on its deposits of cash and cash equivalents. For the nine months ended September 30, 2023, four customers represented greater than 10.0% of total revenue, accounting for 22.8%, 17.1%, 11.6% and 10.9% of total revenue, respectively. For the nine months ended September 30, 2022, two customers represented greater than 10.0% of total revenue, accounting for 16.2% and 15.5% of total revenue, respectively. Three customers accounted for 49.2% of accounts receivable, net as of September 30, 2023, accounting for 26.4%, 12.7% and 10.0%, respectively. Two customers accounted for 27.3% of accounts receivable, net as of December 31, 2022, accounting for 17.3% and 10.0%, respectively. Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition. Certain materials used by the Company in the manufacturing of its products are purchased from a limited number of suppliers. Should any such supplier cease to manufacture the products the Company purchases from them or become unable to timely deliver these products in accordance with the Company’s requirements or should such suppliers choose not to do business with the Company, it may be required to locate alternative suppliers in the open market. There can be no assurance that the Company would be able to identify new suppliers with which to do business on terms acceptable to the Company, or at all. For the nine months ended September 30, 2023, each of three suppliers accounted for 23.2%, 21.9%, and 20.5% of total purchases, respectively. For the nine months ended September 30, 2022, each of four suppliers accounted for 26.7%, 12.9%, 11.2%, and 10.1% of total purchases, respectively. Segment Reporting Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company operates and manages its business as one reportable and operating segment. The Company’s chief executive officer, who is the chief operating decision maker, reviews financial information on a consolidated basis for purposes of allocating resources and assessing performance. All material long-lived assets are maintained in the United States. See “Concentration of Credit Risk and Other Risks and Uncertainties” for further information on revenue by customer and Note 2 for further information on revenue by geography and categorized by products and services. Reverse Stock Split On July 25, 2023, the Company held its 2023 annual meeting of stockholders (the “Annual Meeting”), at which the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the common stock at a reverse stock split ratio of 40-for-1, 45-for-1, 50-for-1, 55-for-1 or 60-for-1, such ratio to be fixed by the Company’s board of directors at a later date. Following the Annual Meeting, on July 25, 2023, the Company’s board of directors approved the implementation of the reverse stock split at a ratio of 60-for-1 (the “Reverse Stock Split”). On July 26, 2023, the Company filed a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a 60-for-1 reverse stock split of the outstanding shares of the Company’s Class A common stock. The Reverse Stock Split became effective upon the filing of the Certificate of Amendment on July 26, 2023 and the Company’s common stock began trading on a split-adjusted basis at market open on July 27, 2023. No fractional common shares were issued as a result of the Reverse Stock Split. Any stockholder who would have been entitled to receive a fractional share as a result of the Reverse Stock Split received cash payments in lieu of such fractional shares. All share and per share information included in the accompanying financial statements has been retrospectively adjusted to reflect this Reverse Stock Split.

Revenue

Revenue	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Disaggregation of Revenue The Company disaggregates revenue between products and services, as well as by major product offering and by geographic market that depict the nature, amount, and timing of revenue and cash flows. The following table summarizes the Company’s revenue by products and services (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue: Products $ 37,131 $ 21,548 $ 82,640 $ 52,461 Services 1,089 2,214 1,962 4,629 Total $ 38,220 $ 23,762 $ 84,602 $ 57,090 View Smart Glass contracts to provide Controls, Software and Services (“CSS”) include the sale of both products and services. These services primarily relate to CSS installation and commissioning and are presented in the table above as Services. Also included within Services in the table above are revenues associated with extended or enhanced warranties. View Smart Glass contracts to provide insulating glass units (“IGUs”), View Smart Building Platform contracts and View Smart Building Technologies contracts relate to the sale of products. The following table summarizes the Company's revenue by major product offering (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue: Smart Building Platform $ 25,031 $ 11,317 $ 53,688 $ 29,578 Smart Glass 11,156 10,320 23,529 19,809 Smart Building Technologies 2,033 2,125 7,385 7,703 Total $ 38,220 $ 23,762 $ 84,602 $ 57,090 The following table summarizes the Company’s revenue by geographic area, which is based on the shipping addresses of the customers (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue: United States $ 37,500 $ 21,743 $ 80,470 $ 52,852 Canada 720 2,009 4,132 4,170 Other — 10 — 68 Total $ 38,220 $ 23,762 $ 84,602 $ 57,090 Contract Estimates Significant changes in estimated costs expected to complete View Smart Building Platform contracts could affect the profitability of our contracts. Changes to estimated profit on contracts are recognized using a cumulative catch-up adjustment which recognizes in the current period the cumulative effect of the changes on current and prior periods based on a contract’s progress towards fulfillment of the performance obligation. When the total estimated costs to be incurred for a contract exceed the transaction price, an accrual for the loss on the contract is recognized as cost of revenue in the period the contract is signed, and adjusted periodically as estimates are revised. As actual costs are incurred that are in excess of revenue recognized, they are recorded against the loss accrual, which is therefore reduced. During the three months ended September 30, 2023 and 2022, the Company recognized a total of $0.2 million and $1.5 million, respectively, for initial contract loss accruals and incurred $5.3 million and $4.2 million, respectively, of previously accrued losses, which resulted in a decrease to the accrual. During the nine months ended September 30, 2023 and 2022, the Company recognized a total of $1.8 million and $4.0 million, respectively, for initial contract loss accruals and incurred $13.5 million and $12.3 million, respectively, of previously accrued losses, which resulted in a decrease to the accrual. The cumulative catch-up adjustments resulting from changes in estimated profit on contracts were nil and $0.6 million for the three months ended September 30, 2023 and 2022, respectively. The cumulative catch-up adjustments resulting from changes in estimated profit on contracts were $(3.8) million and $1.4 million for the nine months ended September 30, 2023 and 2022, respectively. The balance of estimated contract losses for work that had not yet been completed totaled $7.1 million and $15.0 million as of September 30, 2023 and December 31, 2022, respectively. Remaining Performance Obligations The Company’s IGU contracts are short-term in nature and the practical expedient has been applied. The Company’s performance obligations in CSS contracts are generally short-term in nature, for which the practical expedient has been applied, with the exception of commissioning services, which are provided at the end of a construction project. Revenue for commissioning services performance obligations is not material. The Company’s performance obligations in Smart Building Platform contracts are longer-term in nature, however many of these contracts provide the customer with a right to cancel or terminate for convenience with no substantial penalty. The transaction price allocated to remaining performance obligations for non-cancelable Smart Building Platform contracts as of September 30, 2023 was $6.1 million that the Company expects to recognize as it satisfies the performance obligations over the next 12 to 24 months, which are, among other things, dependent on the construction schedule of the site for which the Company's products and services are provided. The Company’s performance obligations in Smart Building Technologies contracts are generally short-term in nature, for which the practical expedient has been applied. Contract Assets and Liabilities Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing, where payment is conditional, as well as retainage for amounts that the Company has billed to the customer but are being held for payment by the customer pending satisfactory completion of the project. Current contract assets as of September 30, 2023 and December 31, 2022 were $20.4 million and $14.6 million, respectively. The progress billing schedules for these contracts result in timing differences as compared to the Company’s satisfaction of its performance obligation. Non-current contract assets as of September 30, 2023 and December 31, 2022 were $1.2 million and $0.7 million, respectively, and were included in other assets. Contract liabilities relate to amounts invoiced or consideration received from customers, typically for the Company’s CSS contracts, in advance of the Company’s satisfaction of the associated performance obligation. Such contract liabilities are recognized as revenue when the performance obligation is satisfied. Contract liabilities are presented as deferred revenue on the condensed consolidated balance sheets.

Fair Value

Fair Value	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value	Fair Value The following table presents information about the Company’s financial assets and liabilities measured at fair value on a recurring basis (in thousands): September 30, 2023 Level 1 Level 2 Total Cash equivalents: Money market funds $ 32,315 $ — $ 32,315 Restricted cash: Certificates of deposit — 14,726 14,726 Total assets measured at fair value $ 32,315 $ 14,726 $ 47,041 December 31, 2022 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 66,614 $ — $ — $ 66,614 Restricted cash: Certificates of deposit — 18,308 — 18,308 Short-term investments — 102,284 — 102,284 Total assets measured at fair value $ 66,614 $ 120,592 $ — $ 187,206 Sponsor earn-out liability $ — $ — $ 506 $ 506 Private warrants liability — — 7 7 Total liabilities measured at fair value $ — $ — $ 513 $ 513 The following table provides a reconciliation of the beginning and ending balances for the level 3 financial liabilities measured at fair value using significant unobservable inputs (in thousands): Sponsor Private Balance as of December 31, 2022 $ 506 $ 7 Change in fair value (506) (7) Balance as of September 30, 2023 $ — $ — Sponsor Earn-out Shares, as defined below, and the Company’s privately placed warrants (“Private Warrants”) are subject to remeasurement to fair value at each balance sheet date. Changes in fair value as a result of the remeasurement are recognized in gain on fair value change, net in the condensed consolidated statements of comprehensive loss. The following table summarizes the gain on fair value change, net (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Sponsor Earn-out Liability $ — $ (225) $ (506) $ (6,364) Private Warrants — (1) (7) (147) Gain on fair value change, net $ — $ (226) $ (513) $ (6,511) Valuation of Sponsor Earn-Out Liability In conjunction with the Company’s merger completed on March 8, 2021, CF Finance Holdings II, LLC (the “Sponsor”) subjected 82,835 shares (the “Sponsor Earn-Out Shares”) to vesting and potential forfeiture (and related transfer restrictions) based on a five year post-closing earnout, with (a) 50% of the Sponsor Earn-Out Shares being released if the stock price of the Company exceeds $750.00 for 5 out of any 10 trading days, (b) 25% of the Sponsor Earn-Out Shares being released if the stock price of the Company exceeds $900.00 for 5 out of any 10 trading days and (c) 25% of the Sponsor Earn-Out Shares being released if the stock price of the Company exceeds $1,200.00 for 5 out of any 10 trading days, in each case, subject to early release for a sale, change of control or going private transaction or delisting after March 8, 2021 (collectively, the “Earn-Out Triggering Events”). The estimated fair value of the Sponsor Earn-Out Shares of $0.0 million and $0.5 million as of September 30, 2023 and December 31, 2022, respectively, was determined using a Monte Carlo simulation valuation model using the following assumptions: September 30, 2023 December 31, 2022 Stock price $7.51 $57.90 Expected volatility 64.25% 69.25% Risk free rate 4.90% 4.22% Expected term (in years) 2.4 3.2 Expected dividends 0% 0% Current stock price: The stock price was based on the closing price as of the valuation date. Expected volatility: The volatility rate was determined using a Monte Carlo simulation to estimate the implied volatility of the Company’s publicly traded warrants (“Public Warrants”). Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve for zero-coupon U.S. Treasury notes with maturities corresponding to the remaining expected term of the earnout period. Expected term: The expected term is the remaining contractual term of the earnout period. Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends in the foreseeable future. Valuation of Private Warrants The estimated fair value of the Private Warrants of $0.0 million as of both September 30, 2023 and December 31, 2022, was determined using the Black-Scholes option-pricing model using the following assumptions: September 30, 2023 December 31, 2022 Stock price $7.51 $57.90 Expected volatility 64.25% 69.25% Risk free rate 5.07% 4.32% Expected term (in years) 1.9 2.7 Expected dividends 0% 0% Other The carrying amounts of cash equivalents relating to demand deposits and U.S. Treasury bills, accounts receivable, and accounts payable approximates fair value due to the short maturity of these instruments. The carrying amount of long-term trade receivables approximates fair value, which is estimated by discounting expected future cash flows using an average discount rate adjusted for the customer's creditworthiness. Short-term and long-term debt associated with the term loan are carried at amortized cost, which approximates its fair value. The Convertible Notes are carried at amortized cost and their fair value is determined using Level 3 inputs, as discussed further in Note 7 .

Other Balance Sheet Information

Other Balance Sheet Information	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Other Balance Sheet Information	Other Balance Sheet Information Cash, Cash Equivalents and Restricted Cash Cash, cash equivalents, and restricted cash reported within the accompanying condensed consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying condensed consolidated statements of cash flows consisted of the following (in thousands): September 30, 2023 December 31, 2022 Cash $ 18,303 $ 29,244 Cash equivalents 32,315 66,614 Cash and cash equivalents 50,618 95,858 Short-term restricted cash 14,000 1,859 Restricted cash 726 16,448 Total cash, cash equivalents, and restricted cash presented in the statements of cash flows $ 65,344 $ 114,165 Short-Term Investments The Company had no short-term investments as of September 30, 2023. Short-term investments as of December 31, 2022 consisted of the following: Amortized Cost Unrealized Gain/(Loss) Fair Value Commercial Paper $ 59,684 $ — $ 59,684 Corporate Notes/Bonds 4,914 — 4,914 U.S. Treasuries 31,804 — 31,804 U.S. Government Agencies 5,882 — 5,882 Total short-term investments $ 102,284 $ — $ 102,284 The Company’s marketable debt securities had contractual maturities of less than one year, were classified as available-for-sale and were stated at fair value on the consolidated balance sheets based upon inputs other than quoted prices in active markets (Level 2 inputs). The Company did not record any unrealized gains or losses or recognize any gains or losses for three and nine months ended September 30, 2023 and 2022. The Company also did not recognize any credit-related impairment losses during the three and nine months ended September 30, 2023 and 2022 and had no ending allowance for credit losses as of September 30, 2023 and December 31, 2022. The amortized cost and fair value amounts above include accrued interest receivable of $0.7 million as of December 31, 2022. Accounts Receivable, Net of Allowances During the three and nine months ended September 30, 2023, the Company recorded a $0.7 million increase in the allowance for credit losses. The Company regularly reviews accounts receivable for collectability and establishes or adjusts the allowance for credit losses as necessary using the specific identification method based on the available facts. The allowance for credit losses totaled $1.8 million and $1.1 million as of September 30, 2023 and December 31, 2022, respectively. Inventories Inventories consist of finished goods which are stated at the lower of cost or net realizable value. Costs are measured on a first-in, first out basis using standard cost, which approximates actual cost. Net realizable value is the estimated selling price of the Company’s products in the ordinary course of business less reasonably predictable costs of completion, disposal, and transportation. Inventories are written down to their net realizable value if they have become obsolete, have a cost basis in excess of expected net realizable value, or are in excess of expected demand. Once inventory is written down, its new value is maintained until it is sold, scrapped, or written down for further valuation losses. The valuation of inventories requires the Company to make judgments based on currently available information about the likely method of disposition and current and future product demand relative to the remaining product life. Inventory valuation losses are classified as cost of revenue in the condensed consolidated statements of comprehensive loss. The Company recorded inventory impairments of $8.4 million and $14.2 million for the nine months ended September 30, 2023 and 2022, respectively. Note Receivable In June 2021, the Company entered into a promissory note with one of its customers, pursuant to which the customer has drawn an aggregate principal amount of $10.0 million. The promissory note has a maturity date of May 1, 2026. The promissory note bears no interest during the period between the first advance to the customer and the thirty-first month following the first advance, with interest increasing to an annual rate of 3.5% thereafter. The Company recorded a $4.0 million impairment loss on the note receivable during the three months ended June 30, 2023, resulting from a change in the assessment of the credit risk for the customer. No additional impairment loss was recorded during the three months ended September 30, 2023. As of September 30, 2023, $6.0 million related to the note receivable is recorded on the condensed consolidated balance sheet. Impairment of Long-Lived Assets The Company evaluates long-lived assets for impairment whenever events indicate that a potential impairment may have occurred. If such events arise, the Company will compare the carrying amount of the asset group comprising the long-lived assets to the estimated future undiscounted cash flows expected to be generated by the asset group. If the estimated aggregate undiscounted cash flows are less than the carrying amount of the asset group, an impairment charge is recorded as the amount by which the carrying amount of the asset group exceeds the fair value of the assets, as based on the expected discounted future cash flows attributable to those assets. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell. During the third quarter of 2023, due to a continued decline in economic and market conditions, including a continued and sustained decline in the Company’s market capitalization, rising interest rates and a prolonged outlook for a continued slow-down in the real estate market, as well as a limited amount of additional financing being secured and revised projections for the Company’s future operating results, the Company determined that a triggering event existed requiring the Company’s assets to be evaluated for impairment as of September 30, 2023. As a result, the Company performed an interim quantitative impairment analysis as of this date. The Company has no indefinite-lived intangible assets and no goodwill as of September 30, 2023, and therefore the impairment assessment was limited to long-lived assets under ASC 360-10. As noted in Note 1 , the Company operates and manages its business as one reportable and operating segment. The Company determined that the asset group is the operating segment for the purposes of the impairment assessment for long-lived assets. The long-lived assets are primarily comprised of property and equipment and operating lease right-of-use assets. The Company compared the carrying value of the asset group to separately identifiable estimated undiscounted cash flows over the remaining useful life of the asset group and concluded that the asset group was not recoverable due to the carrying value exceeding the estimated undiscounted cash flows. As the asset group failed the recoverability test, there was an indicator of impairment loss, which required the Company to determine whether the carrying amount of the asset group exceeded its fair value. The Company determined the fair value of the asset group based on the total invested capital of the Company as of September 30, 2023, including the fair value of the Company’s long-term debt and shareholders’ equity. The Company’s long-term debt consists of the Convertible Notes and the Term Loan. The fair value of the Convertible Notes was determined using the Tsiveriotis-Fernandes model. This model utilized a binomial lattice tree in a risk-neutral framework, which involved calibrating the model at the date of issuance to derive the initial risky asset rate, updating the risky asset rate by considering changes in the prevailing yields and spreads on comparable instruments between the issuance date and September 30, 2023, and then calculating the fair value of the Convertible Notes using this updated risky asset rate. The key assumptions used in the valuation of the Convertible Notes included the Company’s current stock price, the expected volatility, the remaining term of the Convertible Notes, the conversion mechanics specific to the Convertible Notes, and the initial risky asset rate. As of September 30, 2023, the fair value of the Convertible Notes was approximately $112 million, as compared to a carrying value of approximately $197 million. As discussed in Note 3 , the amortized cost of the Term Loan approximates its fair value and was approximately $13 million as of September 30, 2023. The fair value of the shareholders’ equity was determined utilizing an income approach based on the present value of the estimated future cash flows. The key assumptions used included cash flow projections, discount rate, and an estimated terminal value. As of September 30, 2023, the fair value of the shareholders’ equity was $17 million, as compared to a carrying value of approximately $102 million. Under the accounting guidance in ASC 360, the excess of the carrying value over the fair value of the asset group was recognized as an impairment loss and allocated to assets for which the carrying value exceeded their respective fair value. Fair value was determined based on our intended use of the identified assets. As such, the Company utilized various methods such as discounted cash flows, replacement cost, scrap and residual value to estimate fair value. Certain assets were not allocated any impairment as the fair values of such assets approximated their respective carrying amounts. Based on the results of the analysis, the Company recorded an impairment charge during the three and nine months ending September 30, 2023 of approximately $170 million to write down the value of property and equipment. If the decline in the Company’s market capitalization continues, the Company is unable to obtain additional financing as discussed in Note 1 , or the Company identifies other events or circumstances indicating the carrying amount of an asset or asset group may not be recoverable, this would require further testing of these assets and it may result in an impairment of such assets. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): September 30, 2023 December 31, 2022 Warranty accrual ( Note 5 ) $ 13,945 $ 10,236 Contract loss accrual ( Note 2 ) 6,842 12,848 Environmental settlement accrual ( Note 6 ) 1,000 1,450 Lease liability 3,733 3,949 Subcontractor accrual 16,312 18,435 Other 15,377 25,492 Accrued expenses and other current liabilities $ 57,209 $ 72,410

Product Warranties

Product Warranties	9 Months Ended
	Sep. 30, 2023
Guarantees and Product Warranties [Abstract]
Product Warranties	Product Warranties Changes in warranty liabilities are presented below (in thousands): September 30, 2023 December 31, 2022 Beginning balance $ 39,573 $ 42,256 Accruals for warranties issued 1,682 1,626 Changes to estimates of volume and costs 3,991 2,004 Settlements made (4,312) (6,313) Ending balance $ 40,934 $ 39,573 Warranty liability, current, beginning balance $ 10,236 $ 8,868 Warranty liability, noncurrent, beginning balance $ 29,337 $ 33,388 Warranty liability, current, ending balance $ 13,945 $ 10,236 Warranty liability, noncurrent, ending balance $ 26,989 $ 29,337 The total warranty liability above included $9.8 million and $8.8 million as of September 30, 2023 and December 31, 2022, respectively, related to the Company' standard assurance warranty. The total warranty liability above also included $31.1 million and $30.8 million as of September 30, 2023 and December 31, 2022, respectively, related to certain IGUs with a quality issue identified during fiscal year 2019. The quality issue was specific to certain material purchased from one of the Company’s suppliers utilized in the manufacturing of certain IGUs and the Company stopped using the affected materials upon identification of the quality issue in 2019. The Company has replaced and expects to continue to replace the affected IGUs for the remainder of the period covered by the warranty. The Company developed a statistical model to analyze the risk of failure of the affected IGUs related to this quality issue and predict the potential number of future failures that may occur during the remaining warranty period, as well as the timing of the expected failures. Management judgment is necessary to determine the distribution fit and covariates utilized in the statistical model, as

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Indemnifications From time to time, the Company enters into certain types of contracts that contingently require the Company to indemnify the Company's officers, directors, and employees for liabilities arising out of their employment relationship. Generally, a maximum obligation under these contracts is not explicitly stated. Because the maximum amounts associated with these agreements are not explicitly stated, the overall maximum amount of the obligation cannot be reasonably estimated. The Company has not been required to make payments under these obligations, and no liabilities have been recorded for these obligations on the Company's condensed consolidated balance sheets. Standby Letter of Credit During the course of business, the Company’s bank issues standby letters of credit on behalf of the Company to certain vendors and other third parties of the Company. As of September 30, 2023 and December 31, 2022, the total value of the standby letters of credit issued by the bank is $13.8 million and $15.7 million, respectively. As of September 30, 2023, $1.0 million had been drawn under the standby letters of credit. Litigation and Environmental Settlements In December 2014, the Company finalized the terms of a litigation settlement with a third party where the Company agreed to pay the other party a total of $32.0 million periodically over the next ten years. The Company recorded the present value of future payments as a liability and records interest expense, included in interest and other, net in the condensed consolidated statements of comprehensive loss, as it accretes the liability. The balances of the litigation settlement liability are recorded in accrued expenses and other current liabilities and other liabilities, respectively, on the Company’s condensed consolidated balance sheets as follows (in thousands): September 30, 2023 December 31, 2022 Litigation settlement liability - current $ 3,000 $ 3,000 Litigation settlement liability - non-current 3,332 5,794 Total litigation settlement liability $ 6,332 $ 8,794 In August 2023, the Company finalized the terms of an environmental settlement with the Mississippi Commission on Environmental Quality (“MCEQ”), Desoto County Regional Utility Authority (“DCRUA”) and the City of Olive Branch, Mississippi (“Olive Branch”) where the Company agreed to pay a fine of $3.0 million over a three-year period in equal installments of $1.0 million to the federal government, a civil penalty of $1.5 million to MCEQ and a community service payment of $0.5 million to DCRUA. The Company has also completed the installation of a wastewater treatment and recycling system, which resulted in approximately $4.8 million in capital expenditures as of September 30, 2023. The Company will also be on probation for three years. The balances of the environmental settlement liability are recorded in accrued expenses and other current liabilities and other liabilities, respectively, on the Company’s condensed consolidated balance sheets as follows (in thousands): September 30, 2023 December 31, 2022 Environmental settlement liability - current $ 1,000 $ 1,450 Environmental settlement liability - non-current 1,000 3,000 Total environmental settlement liability $ 2,000 $ 4,450 Litigation From time to time, the Company is subject to claims, litigation, internal or governmental investigations, including those related to labor and employment, contracts, intellectual property, environmental, regulatory compliance, commercial matters, and other related matters, some of which allege substantial monetary damages and claims. Some of these actions may be brought as class actions on behalf of a class or purported class of employees. The Company is also defendant in judicial and administrative proceedings involving matters incidental to the business. Legal expenses are expensed as incurred. The Company accrues a charge when management determines that it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. When a loss is probable, the Company records an accrual based on the reasonably estimable loss or range of loss. When no point of loss is more likely than another, the Company records the lowest amount in the estimated range of loss and discloses the estimated range. The Company does not record liabilities for reasonably possible loss contingencies but does disclose a range of reasonably possible losses if they are material and the Company is able to estimate such a range. If the Company cannot provide a range of reasonably possible losses, the Company explains the factors that prevent it from determining such a range. The Company regularly evaluates current information available to it to determine whether an accrual should be established or adjusted. The ultimate outcome of legal proceedings involves judgments, estimates, and inherent uncertainties and cannot be predicted with certainty. Should the ultimate outcome of any legal matter be unfavorable, the Company's business, financial condition, results of operations, or cash flows could be materially and adversely affected. The Company may also incur substantial legal fees, which are expensed as incurred, in defending against legal claims. Securities Litigation On August 18, 2021, plaintiff Asif Mehedi filed a putative securities class action in the United States District Court for the Northern District of California (Mehedi v. View, Inc. f/k/a CF Finance Acquisition Corp. II et al. (No. 5:21CV06374, N.D. Cal.)) alleging violations of the federal securities laws by the Company, Rao Mulpuri, and Vidul Prakash. On February 8, 2022, the Court appointed Stadium Capital LLC (“Stadium Capital”) lead plaintiff and denied the competing motion of Sweta Sonthalia. The Ninth Circuit Court of Appeals denied Ms. Sonthalia’s petition for a writ of mandamus to vacate the lead plaintiff order. On July 15, 2022, Stadium Capital filed an amended complaint against View, Mulpuri, and Prakash; certain current and former View board members; Cantor Fitzgerald & Co. and related entities; officers and board members of CF Finance Acquisition Corp. II (“CF II”); and PricewaterhouseCoopers LLP (“PwC”). The action was brought on behalf of a putative class consisting of (i) all persons or entities who purchased or otherwise acquired View and/or CF II securities between November 30, 2020 and May 10, 2022, inclusive; (ii) all persons or entities who were holders of CF II Class A common stock as of the January 27, 2021 record date that were entitled to vote to approve the merger between View and CF II; and (iii) all persons or entities who purchased or otherwise acquired View securities pursuant or traceable to the Form S-4 Registration Statement filed by CF II on December 23, 2020. The amended complaint asserted claims under Sections 10(b) (and Rule 10b-5 thereunder), 14(a) (and Rule 14a-9 thereunder), and 20(a) of the Securities Exchange Act and Sections 11, 12, and 15 of the Securities Act. Defendants filed motions to dismiss the amended complaint on October 6, 2022. The motions were heard by the court on April 20, 2023. On May 22, 2023, the court issued a written order granting the motions to dismiss with leave to amend. On August 21, 2023, Stadium Capital and additional plaintiff David Sherman filed a second amended complaint against View, Mulpuri, and Prakash; Cantor Fitzgerald & Co. and related entities; and officers and board members of CF II. The second amended complaint asserts claims under Sections 10(b) (and Rule 10b-5 thereunder), 14(a) (and Rule 14a-9 thereunder), and 20(a) of the Securities Exchange Act. The action is brought on behalf of a putative class consisting of (i) all persons or entities who purchased or otherwise acquired View and/or CF II securities between November 30, 2020 and November 9, 2021, inclusive; and (ii) all persons or entities who were holders of CF II Class A common stock as of the January 27, 2021 record date that were entitled to vote to approve the merger between View and CF II. The second amended complaint dropped as defendants the current and former View board members and PwC; it also dropped the claims under Sections 11, 12, and 15 of the Securities Act. The second amended complaint alleges that defendants failed to disclose to investors that the Company’s warranty-related obligations and associated cost of revenue were materially false and misleading because they excluded installation expenses the Company was incurring to address certain warrantied quality issues, and that the Company was incurring those expenses even though the standard warranty did not obligate the Company to do so. As a result, the second amended complaint alleges that the price of the Company’s stock was inflated. The second amended complaint alleges that class members were damaged when the price of the Company’s stock declined on the trading day following (1) August 16, 2021, when the Company announced an independent investigation concerning the adequacy of the Company’s previously disclosed warranty accrual, and (2) November 9, 2021, when the Company announced that its independent investigation was substantially complete, that the Company’s previously reported warranty-related liabilities were materially misstated, and that it would restate certain previously reported financials. The second amended complaint seeks unspecified compensatory damages and costs, including attorneys’ fees. Defendants filed motions to dismiss the second amended complaint on October 2, 2023. Plaintiff’s opposition brief to those motions is due November 13, 2023, Defendants’ reply briefs are due December 8, 2023, and the motions will be heard by the court on March 14, 2024. Given the possibility that the plaintiff may amend its complaint, the Company cannot reasonably estimate the possible loss (or range of loss), if any, at this time; therefore, a liability has not been recorded as of September 30, 2023. Derivative Litigation On December 6, 2021, a purported Company shareholder, Matthew Jacobson, filed a verified stockholder derivative complaint (nominally on behalf of the Company) against Rao Mulpuri, Nigel Gormly, Harold Hughes, Tom Leppert, Toby Cosgrove, Lisa Picard, Julie Larson-Green, and Vidul Prakash (Jacobson v. Mulpuri, et al. (No. 1:21CV01719, D. Del.)). On May 24, 2022, plaintiff and purported Company shareholder Anil Damidi filed a verified stockholder derivative complaint (nominally on behalf of the Company) against the same defendants as in the Jacobson complaint: Mr. Mulpuri, Mr. Gormly, Mr. Hughes, Mr. Leppert, Mr. Cosgrove, Ms. Picard, Ms. Larson-Green, and Mr. Prakash. On July 26, 2022, plaintiff and purported Company stockholder James Monteleone filed a verified stockholder derivative complaint (nominally on behalf of the Company) against the same defendants as in the Jacobson and Damidi complaints: Mr. Mulpuri, Mr. Gormly, Mr. Hughes, Mr. Leppert, Mr. Cosgrove, Ms. Picard, Ms. Larson-Green, and Mr. Prakash. On September 8, 2022, the Jacobson, Damidi, and Monteleone cases were assigned to Judge Gregory Williams. On September 30, 2022, Judge Williams entered the parties’ stipulation to (1) consolidate the three actions into In re View, Inc. Derivative Litigation, C.A. No, 21-1719-GBW (Consolidated), (2) appoint co-lead counsel for plaintiffs, and (3) stay all proceedings in the consolidated action until the Mehedi class action is dismissed in its entirety, with prejudice, and all appeals related thereto have been exhausted, or is resolved by settlement, or the motions to dismiss in the Mehedi class action are denied. Any party may request that the Court lift the stay upon good cause shown and bringing the matter to the Court’s attention. The stipulation deems the Damidi complaint to be the operative complaint in the consolidated case until any amended complaint is filed. The Damidi complaint asserts claims for violation of Sections 10(b) and 21D of the Exchange Act, breach of fiduciary duty, aiding and abetting breach of fiduciary duty, unjust enrichment, and waste of corporate assets. The Damidi complaint seeks unspecified money damages, restitution, punitive damages, and costs (including attorneys’ fees and accountants’ and experts’ fees, costs, and expenses). The Damidi complaint alleges that the defendants failed to prevent the Company from making false statements regarding the Company’s business results and prospects and that the Company has been harmed by incurring legal fees and potential liability in investigations and lawsuits. On May 9, 2023, plaintiff and purported Company shareholder Alexandre Roberts filed a verified stockholder derivative complaint (nominally on behalf of the Company) against Rao Mulpuri, Vidul Prakash, Toby Cosgrove, Lisa Picard, and Nigel Gormly ( Roberts v. Mulpuri, et al. (No. 5:23-cv-02248, N.D. Cal.)). The complaint asserts claims for breach of fiduciary duty, unjust enrichment, waste of corporate assets, and contribution under Section 10(b) and/or Section 20(a) of the Exchange Act. The complaint seeks unspecified money damages, restitution, punitive damages, and costs (including attorneys’ fees and experts’ fees, costs, and expenses). The Roberts complaint alleges that the defendants failed to prevent the Company from making false statements regarding the Company’s business results and prospects and that the Company has been harmed by incurring legal fees and potential liability in lawsuits. On August 1, 2023, the judge in the Mehedi case ordered that the Roberts case should be related to the Mehedi case and ordered that the Roberts case should be reassigned to the Mehedi judge. Given the early stage of this matter, the Company cannot reasonably estimate the possible loss (or range of loss), if any, at this time; therefore, a liability has not been recorded as of September 30, 2023. Government Investigations On November 9, 2021, the Company announced that it had voluntarily reported to the SEC that the audit committee of the Company’s board of directors was conducting an independent, internal investigation into the adequacy of the Company’s previously reported warranty accrual. In January 2022, the Company was informed that the SEC was conducting a formal investigation of this matter. In June 2022, the U.S. Attorney’s Office for the Southern District of New York requested

Debt

Debt	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Debt	Debt Debt outstanding consisted of the following (in thousands): September 30, 2023 December 31, 2022 Convertible Notes, net of debt issuance costs $ 196,576 $ 206,347 Term loan 13,225 13,960 Total debt 209,801 220,307 Debt, current 1,470 1,470 Debt, non-current $ 208,331 $ 218,837 Principal payments on all debt outstanding as of September 30, 2023 are estimated as follows (in thousands): Year Ending December 31, Total 2023 (remaining three months) $ 735 2024 1,470 2025 1,470 2026 1,470 2027 198,046 Thereafter 6,610 Total $ 209,801 Convertible Notes The following tables present the Company’s convertible debt outstanding (in thousands): September 30, 2023 Gross amount Debt discount and issuance costs Carrying amount Estimated fair value Convertible Notes $ 201,607 $ (5,031) $ 196,576 $ 111,627 December 31, 2022 Gross amount Debt discount and issuance costs Carrying amount Estimated fair value Convertible Notes $ 212,308 $ (5,961) $ 206,347 $ 199,163 The following table presents the Company’s interest expense related to convertible debt (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Contractual interest expense $ 4,536 $ — $ 13,409 $ — Amortization of debt discount and issuance costs 295 — 719 — Total interest expense $ 4,831 $ — $ 14,128 $ — In October 2022, the Company completed the sale of $200.0 million aggregate principal amount of the Company’s 6.00% / 9.00% Convertible Senior PIK Toggle Notes (the “Initial Notes”), with the option to sell an additional $40.0 million of Notes to the Purchasers (as defined in the indenture governing the Convertible Notes). In December 2022, the Company received notices from certain Purchasers that had elected to exercise their respective options to purchase an aggregate additional $12.3 million of Convertible Notes (the “Additional Notes”). Such Additional Notes were issued in December 2022. The Initial Notes and the Additional Notes, which will be collectively referred to as the Convertible Notes, will mature on October 1, 2027. The Convertible Notes were sold in a private placement in reliance on the exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”) provided by Section 4(a)(2) of the Securities Act. The net proceeds from the sale of the Convertible Notes were approximately $206.3 million after deducting fees and offering expenses. The debt discount and issuance costs, net of accumulated amortization, are reported as a direct deduction from the face amount of the Convertible Notes. The Company expects to use the net proceeds for general corporate purposes. The Convertible Notes bear interest at 6.00% per annum, to the extent paid in cash (“Cash Interest”), and 9.00% per annum, to the extent paid in kind through the issuance of additional Convertible Notes (“PIK Interest”). Interest is payable semi-annually in arrears on April 1 and October 1 of each year, beginning on April 1, 2023. The Company can elect to make any interest payment through Cash Interest, PIK Interest or any combination thereof. The Convertible Notes are convertible, based on the applicable conversion rate, into cash, shares of the Company’s common stock or a combination thereof, at the Company’s election. The initial conversion rate was 12.46106 shares per $1,000.00 principal amount of the Convertible Notes, subject to customary anti-dilution adjustment in certain circumstances, which represented an initial conversion price of approximately $80.25 per share. The Convertible Notes will be convertible at the option of the holders at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the Convertible Notes. In connection with the issuance of the Convertible Notes, the Company entered into letter agreements with certain Purchasers (the “Blocker Agreements”). The Blocker Agreements provide, among other things, that the Convertible Notes held by the entities affiliated with certain holders (each, a “Blocker Party”), shall not be converted to the extent that such conversion would cause a Blocker Party to beneficially own more than a specified threshold percentage (as may be increased or decreased by the applicable Blocker Party upon 61 days’ written notice) of the Class A common stock, par value $0.0001 per share, of the Company outstanding immediately following such conversion. The Company may redeem the Convertible Notes in whole or in part, at its option, on or after October 1, 2025, and prior to the 41st scheduled trading day immediately preceding the maturity date, for cash at the applicable redemption price if the last reported sale price of the Company’s common stock has been at least 150% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides the applicable redemption notice. The redemption price will be equal to the aggregate principal amount of the Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. In addition, a holder may elect to convert its Convertible Notes during any such redemption period, in which case the applicable conversion rate may be increased in certain circumstances if the Convertible Notes are converted after they are called for redemption. Additionally, if the Company undergoes a fundamental change transaction (each such term as defined in the indenture governing the Convertible Notes), subject to certain conditions, holders may require the Company to purchase for cash all or any portion of their Convertible Notes. The fundamental change repurchase price will be 100% of the capitalized principal amount of the Convertible Notes, plus any accrued and unpaid interest to, but excluding, the repurchase date. The indenture governing the Convertible Notes contains customary terms and covenants, including certain events of default in which case either the trustee or the holders of at least 25% of the aggregate principal amount of the outstanding Convertible Notes may declare 100% of the principal of, and accrued and unpaid interest, if any, on, all the Convertible Notes to be due and payable immediately. As of September 30, 2023, the effective interest rate on the Convertible Notes was 9.82%. Amortization of debt discount and issuance costs is reported as a component of interest expenses and is computed using the straight-line method over the term of the Convertible Notes, which approximates the effective interest method. During the nine months ended September 30, 2023, the Company elected the PIK Interest option and accrued interest of $7.3 million was added to the principal balance of the Convertible Notes. On January 12, 2023, holders of $18.0 million in aggregate principal amount of the Convertible Notes exercised their right to convert their Convertible Notes into shares at the conversion price of $64.20 per share. As a result, the Company issued 280,373 shares of its Class A common stock, par value $0.0001 per share. Term Loan On November 22, 2010, the Company entered into a debt arrangement with a lender, in an amount of $40.0 million (the “Term Loan”), for the purpose of financing equipment and tenant improvements at its manufacturing facility in Olive Branch, Mississippi. Pursuant to the original terms, the loan provides for interest-free debt to be repaid in semi-annual payments due on June 30 and December 31 each year. The loan was originally being paid over 24 semi-annual installments through June 30, 2024. On October 22, 2020, the Company entered into an amended and restated debt arrangement with the lender. The amended and restated debt arrangement temporarily suspended the payments. Starting June 30, 2022, the Company is required to make semi-annual payments of $0.7 million due on June 30 and December 31 each year through June 30, 2032. The term loan agreement required the Company to invest certain amounts in land, building and equipment and create a certain number of jobs. The term loan agreement, as amended, also includes a covenant for audited consolidated financial statements to be delivered to the lender within 210 days of the Company’s fiscal year end. As of September 30, 2023, the Company was in compliance with these covenants.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2023
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Stockholders’ Equity Common Stock On March 9, 2021, the Company’s common stock and warrants began trading on the Nasdaq Global Select Market under the ticker symbols “VIEW” and “VIEWW,” respectively. Pursuant to the Company’s certificate of incorporation, the Company is authorized to issue 600,000,000 shares of common stock with a par value of $0.0001 per share. As of September 30, 2023, the Company had 4,053,580 shares of common stock issued and outstanding. Preferred Stock Pursuant to the Company’s certificate of incorporation, the Company is authorized to issue 1,000,000 shares of preferred stock having a par value of $0.0001 per share (“View Inc. Preferred Stock”). The Company’s board of directors has the authority to issue View, Inc. Preferred Stock and to determine the rights, preferences, privileges, and restrictions, including voting rights, of those shares. As of September 30, 2023, no shares of View, Inc. Preferred Stock were issued and outstanding. Net Share Settlement of Equity Awards During the three months ended September 30, 2023, the Company withheld 14,035 shares with a fair value of $0.1 million in satisfaction of tax withholding obligations relating to the vesting of restricted share units. During the nine months ended September 30, 2023, the Company withheld 49,389 shares with a fair value of $1.4 million in satisfaction of tax withholding obligations relating to the vesting of restricted share units. During the three and nine months ended September 30, 2022, the Company withheld 31,452 shares with a fair value of $3.1 million in satisfaction of tax withholding obligations relating to the vesting of restricted share units. Shares withheld in satisfaction of tax withholding obligations are retired upon repurchase and returned to the unissued authorized capital of the Company. As of September 30, 2023, no shares of Treasury Stock were issued and outstanding. Convertible Note Conversion As discussed in Note 7 , on January 12, 2023, holders of $18.0 million in aggregate principal amount of the Convertible Notes exercised their right to convert their Convertible Notes into shares at the conversion price of $64.20 per share. As a result, the Company issued 280,373 shares of its Class A common stock, par value $0.0001 per share. No holders of the Convertible Notes exercised their right to convert their Convertible Notes into shares during the three months ended September 30, 2023. Dividend Common stock is entitled to dividends when and if declared by the Company’s board of directors, subject to the rights of all classes of stock outstanding having priority rights to dividends. The Company has not paid any cash dividends on common stock to date. The Company may retain future earnings, if any, for the further development and expansion of its business and has no current plans to pay cash dividends for the foreseeable future. Any future determination to pay dividends will be made at the discretion of the Company’s board of directors and will depend on, among other things, the Company’s financial condition, results of operations, capital requirements, restrictions contained in future agreements and financing instruments, business prospects and such other factors as the Company’s board of directors may deem relevant. Common Stock Purchase Agreement On August 8, 2022, the Company entered into Purchase Agreements with each of CF Principal Investments LLC, a Delaware limited liability company (“Cantor”), and YA II PN, Ltd., a Cayman Islands exempted company (“Yorkville,” and together with Cantor, the “Investors”), relating to a committed equity facility (the “Facility”). Under the terms of the Purchase Agreements, the Company will have the right, from time to time and at its option, to sell to the Investors up to $100.0 million, in the aggregate, of the Company’s common stock (“View Shares”), subject to certain conditions and limitations set forth in the Purchase Agreements. As of September 30, 2023, the Investors have purchased zero View Shares under the Purchase Agreements. Sales of View Shares under the Purchase Agreements, and the timing of any sales, will be determined by the Company from time to time at its sole discretion and will depend on a variety of factors, including, among other things, market conditions, the trading price of the Company’s common stock and determinations by the Company regarding the use of proceeds from such sales. The net proceeds from any sales under the Purchase Agreements will depend on the frequency with, and prices at which View Shares are sold to the Investors. The Company expects to use the proceeds from any sales under the Purchase Agreements for working capital and general corporate purposes. Upon the initial satisfaction of the conditions to the Investors’ obligations to purchase View Shares set forth in the Purchase Agreements (the “Commencement”), including that a registration statement (the “Resale Registration Statement”) registering the resale of View Shares under the Securities Act, is declared effective by the SEC and the Investors are permitted to utilize the prospectus therein to resell all of the View Shares included in such prospectus, the Company will have the right, but not the obligation, from time to time at its sole discretion until the earliest of (i) the first day of the month next following the date that is 36-months after the effective date of the Resale Registration Statement, (ii) the date on which the Investors shall have purchased, in the aggregate, $100.0 million worth of View Shares pursuant to the Purchase Agreements, (iii) the date on which the Company’s common stock shall have failed to be listed or quoted on The Nasdaq Global Market or an alternative market and (iv) the date on which the Company commences a voluntary bankruptcy case or any person commences a proceeding against the Company, a custodian is appointed for the Company or for all or substantially all of its property or the Company makes a general assignment for the benefit of its creditors, to direct the Investors to purchase View Shares as set forth in the Purchase Agreements, by delivering written notice to Cantor or Yorkville prior to 9:00 AM, Eastern Time, on any trading day, subject to maximum amount as set forth in the Purchase Agreements for each such trading day. The purchase price of View Shares that the Company elects to sell pursuant to the Purchase Agreements will be 97% of the volume weighted average price of the Company’s common stock during the applicable purchase date, subject to adjustment if the Company delivers a purchase notice for a purchase in excess of 20% of the total volume of the Company’s common stock traded during the applicable purchase period. The Company will not sell, and the Investors will not purchase, any View Shares pursuant to the Purchase Agreements, if the aggregate number of View Shares issued pursuant to the Purchase Agreements would exceed 19.99% of the voting power or number of shares of the Company’s common stock issued and outstanding immediately prior to the execution of the Purchase Agreements), subject to reduction as described in the Purchase Agreements, unless the Company obtains approval of its stockholders for the sale of View Shares in excess of such amount. In addition, the Company will not sell, and Cantor and Yorkville will not purchase, any View Shares pursuant to the Purchase Agreements, which, when aggregated with all other shares of the Company’s common stock then beneficially owned by such Investor and its affiliates, would result in, in the case of Cantor, the beneficial ownership by Cantor and its affiliates of more than 9.99% of the Company’s outstanding voting power or shares of the Company’s common stock, or in the case of Yorkville and its affiliates, would result in the beneficial ownership by Yorkville and its affiliates of more than 4.99% of the Company’s outstanding voting power or shares of the Company’s common stock. On the date of the Commencement, the Company will issue to Cantor shares of the Company’s common stock with a value of $1.3 million (the “Commitment Fee”) as of the trading day prior to the filing of the Resale Registration Statement as consideration for its irrevocable commitment to purchase View Shares upon the terms and subject to the satisfaction of the conditions set forth in its respective Purchase Agreement. In addition, pursuant to the Purchase Agreements, the Company agreed to reimburse Cantor for certain of its expenses. The Company also entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Investors, pursuant to which the Company has agreed to register the resale of View Shares and the shares constituting the Commitment Fee. The Purchase Agreements and the Registration Rights Agreement contain customary representations, warranties, conditions, and indemnification obligations by each party. The Purchase Agreements also provide that the representations and warranties of the Company (a) that are not qualified by “materiality” or “Material Adverse Effect” (as defined in the Purchase Agreements) must be true and correct in all material respects as of the date of the Commencement, except to the extent such representations and warranties are as of another date, in which case such representations and warranties must be true and correct in all material respects as of such other date, and (b) that are qualified by “materiality” or “Material Adverse Effect” (as defined in the Purchase Agreements) must be true and correct as of the date of the Commencement, except to the extent such representations and warranties are as of another date, in which case such representations and warranties must be true and correct as of such other date. The Purchase Agreements also provide that the representations and warranties of the Company must be true and correct as described in (a) and (b) above as of a date within three trading days following each time the Company files (i) an Annual Report on Form 10-K and certain Annual Reports on Form 10-K/A, (ii) a Quarterly Report on Form 10-Q, (iii) certain Current Reports on Form 8-K containing amended financial information and (iv) the Resale Registration Statement, any New Registration Statement (as defined in the Purchase Agreements) or any supplement or post-effective amendment thereto, subject to certain exceptions and in any event not more than once per calendar quarter. The representations, warranties and covenants contained in the Purchase Agreements and the Registration Rights Agreement were made only for purposes of the Purchase Agreements and the Registration Rights Agreement and as of specific dates, are solely for the benefit of the parties to such agreements and are subject to certain important limitations. The Company has the right to terminate the Purchase Agreements at any time after the date of the Commencement, at no cost or penalty, upon three three

Stock Warrants

Stock Warrants	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Stock Warrants	Stock Warrants Public and Private Warrants Each of the Company’s Public and Private Warrants entitles the holder to purchase one share of the Company’s common stock at a price of $690.00 per share, subject to adjustments. The Warrants became exercisable on August 26, 2021. The Public Warrants and Private Warrants will expire five years after March 8, 2021 and five years after August 26, 2020, respectively. As of September 30, 2023, there were 6,111 Private Warrants and 277,777 Public Warrants outstanding, and no Warrants had been exercised. Strategic Agreement & RXR Warrant Agreements On October 25, 2022, the Company appointed RXR FP Services LLC (“RXR FP”) to render strategic planning and consulting services to the Company and issued warrants to RXR FP (the “RXR Warrants”) to purchase, in the aggregate, 158,518 shares of the Company’s common stock. The RXR Warrants will expire ten years after October 25, 2022. A portion of the RXR Warrants is accounted for as consideration payable to a customer and a portion of the RXR Warrants is accounted for as non-employee stock compensation. The total grant date fair value of the RXR Warrants was $9.2 million, which was accounted for as an upfront payment to RXR FP as their right to receive the RXR Warrants was not contingent on satisfying any vesting conditions. The Company allocated the grant date fair value between consideration payable to a customer and non-employee stock compensation based on the estimated relative fair value of services to be provided by RXR FP. The portion of the RXR Warrants allocated as consideration payable to a customer is accounted for as a reduction to the contract price for contracts with RXR Realty and therefore a reduction to revenue on such contracts. The portion of the RXR Warrants allocated as non-employee stock compensation is accounted for as marketing expense and expensed as incurred. As of September 30, 2023, there were 158,518 RXR Warrants outstanding, and no RXR Warrants had been exercised. Other Warrants The Company previously issued common stock warrants to various service providers, lenders, investors, at various points in time (the “Legacy Warrants”) that are exercisable at various exercise prices and expire at various points in time. During the three months ended September 30, 2023, thirty-eight of the Legacy Warrants expired. During the nine months ended September 30, 2023, 3,509 of the Legacy Warrants expired. On December 1, 2021, in connection with the WorxWell acquisition, the Company issued 16,666 common stock warrants to the seller (the “WorxWell Warrants”). As of September 30, 2023, no WorxWell Warrants had been exercised. The following table summarizes the outstanding common stock warrants: Warrant issue date Types of shares issued Number of Warrants September 30, 2023 Number of Warrants December 31, 2022 Exercise Price Per Warrant Expiry Date August 2010 - June 2011 Common stock — 774 $ 929.40 March 2023 August 2011 - January 2012 Common stock — 887 1,126.80 March 2023 August 2012 Common stock — 756 1,296.00 March 2023 December 2013 Common stock — 1,054 1,554.60 March 2023 April 2016 - November 2018 Common stock 18,923 18,923 1,135.80 Through November 2028 March 2017 Common stock 30,823 30,823 774.60 March 2027 March 2014 Common stock — 38 568.20 August 2023 December 2018 Common stock 415 415 542.40 December 2028 August 2020 Common stock (Private Warrants) 6,111 6,111 690.00 Through March 2026 August 2020 Common stock (Public Warrants) 277,777 277,777 690.00 Through March 2026 December 2021 Common stock (in connection with the WorxWell acquisition) 16,666 16,666 600.00 December 2031 October 2022 Common stock (in connection with the Strategic Agreement with RXR FP) 158,518 158,518 $ 0.60 October 2032 Total stock warrants 509,233 512,742

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation 2021 Equity Incentive Plan The Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”) on March 8, 2021, under which 977,198 shares of common stock were initially reserved for issuance. The 2021 Plan permits the grant of incentive stock options (“Options”), nonstatutory stock options, stock appreciation rights, restricted stock, restricted stock units (“RSUs)”, and stock bonus awards. As of September 30, 2023, the Company had 167,021 shares of common stock reserved for future issuance of equity awards to employees, officers, directors, or consultants under the 2021 Plan. Options The Company assumed approximately 410,955 options outstanding under a previous equity incentive plan under the 2021 Plan. In addition, on March 8, 2021, the Company granted 83,333 options to purchase Class A common stock of the Company (the “Officer Options”) to View’s executive officers. The Officer Options time vest over a four-year period with 25% to vest on the twelve-month anniversary of their grant date of March 8, 2021 and the remaining 75% to vest on a monthly basis over the following thirty-six months. No other options have been granted under the 2021 Plan. The following table summarizes the activity under the 2021 Plan for time vested options: Options Outstanding Number of Weighted- Weighted-Average Aggregate Intrinsic Value 1 Balance as of December 31, 2022 400 $ 567.23 6.0 $ — Granted — — Exercised — — Canceled/forfeited (15) 588.42 Outstanding as of September 30, 2023 385 $ 566.06 5.4 $ — Options vested and expected to vest as of September 30, 2023 386 $ 566.07 5.4 $ — Exercisable as of September 30, 2023 365 $ 564.20 5.2 $ — _______________________ 1 The aggregate intrinsic value is calculated as the difference between the market value of the Company's common shares as of the relevant period end and the respective exercise prices of the options. The market value as of September 30, 2023 and December 31, 2022 was $7.51 and $57.90 per share, respectively, which is the closing sale price of View's common shares on that day as reported by the Nasdaq Global Market. No options have been exercised under this plan in the nine months ended September 30, 2023 and 2022. The total grant date fair value of stock options vested was $3.8 million and $22.3 million during the nine months ended September 30, 2023 and 2022, respectively. As of September 30, 2023, total unrecognized compensation cost related to unvested stock options, net of estimated forfeitures, was $5.3 million and is expected to be recognized over a weighted-average remaining service period of 1.4 years. RSUs 2021 Officer RSUs On March 8, 2021, the Company granted 208,333 RSUs (the “2021 Officer RSUs”) for shares of Class A Common Stock of the Company to View’s executive officers. The 2021 Officer RSUs time vest over a four-year period with 25% to vest on the twelve-month anniversary of their grant date of March 8, 2021 and the remaining 75% to vest on a monthly basis over the following thirty-six months subject to the following market-based vesting. 50% of the 2021 Officer RSUs granted to each executive officer will only vest if the share price hurdle of $900.00 is achieved and the remaining 50% of such 2021 Officer RSUs will vest if the share price hurdle of $1,200.00 is achieved. On August 5, 2022, the Company’s board of directors, upon recommendation of the Compensation Committee, approved an amendment (the “Amendment”) to the 2021 Officer RSUs under the 2021 Plan, which provided that, effective as of September 8, 2022, the market-based vesting conditions applicable to the 2021 Officer RSUs were no longer applicable, and the awards will continue to vest subject only to the time-based vesting conditions, subject to the executive’s continued employment with the Company through each applicable vesting date. Any 2021 Officer RSUs that are not time-vested as of the date of the executive’s termination of employment with the Company shall be forfeited and returned to the 2021 Plan. Except as expressly amended by the Amendment, all the terms and conditions of the 2021 Officer RSUs remained in full force and effect. The Company accounted for the Amendment as a modification of the original awards. At the modification date, the Company calculated the incremental compensation cost of $22.5 million as the excess of the fair value of the modified awards over the fair value of the original awards immediately before the modification. For awards that were vested as of the modification date, the Company recognized $7.9 million of the incremental compensation cost immediately as of the modification date. For awards that were unvested as of the modification date, the sum of the remaining $14.6 million of the incremental compensation cost and the remaining unrecognized compensation cost of $21.2 million for the original awards on the modification date has been and will continue to be recognized over the remaining requisite service period of 2.6 years from the modification date. The 2021 Officer RSUs have been included within the disclosures below for the outstanding RSUs under the 2021 Plan. Other RSUs As of September 30, 2023, the Company has also issued approximately 259,504 RSUs to its employees, directors, and officers (“Others RSUs”) under the 2021 Plan, which vest upon the achievement of specific time-based measures. The fair value for Other RSUs is calculated based on the stock price on the grant date and expensed ratably over the requisite service period, which ranges between one The following table summarizes the activities for the outstanding RSUs under the 2021 Plan during the nine months ended September 30, 2023: Number of Weighted Average Grant Date Fair Value 1 Outstanding as of December 31, 2022 254 $ 240.00 Granted 106 32.89 Vested (131) 170.29 Canceled (30) 69.25 Outstanding as of September 30, 2023 199 $ 201.31 The total grant date fair value of RSUs vested was $22.2 million and $33.5 million during the nine months ended September 30, 2023 and 2022, respectively. As of September 30, 2023, total unrecognized compensation cost related to RSUs, net of estimated forfeitures, was $25.1 million and is expected to be recognized over a weighted-average remaining service period of 2.0 years. To the extent that the actual forfeiture rate is different than what the Company has anticipated, stock-based compensation related to these awards will be different from expectations. CEO Incentive Plan On March 8, 2021, the Company granted the CEO an option award (the “CEO Option Award”) to purchase Class A common stock of the Company at an exercise price of $600.00 per share (the CEO Incentive Plan”), which vests and becomes exercisable upon satisfaction of the performance conditions set forth in the table below, contingent upon the CEO’s continued employment with the Company on each such vesting date. Tranche Option Shares (#) Average 60-day 1 41,666 $ 1,200.00 2 41,666 1,800.00 3 41,666 2,400.00 4 41,666 3,000.00 5 41,666 3,600.00 6 41,666 4,200.00 7 41,666 4,800.00 8 41,666 5,400.00 9 41,666 6,000.00 10 41,666 $ 6,600.00 As of September 30, 2023, total outstanding stock options under the CEO Incentive Plan was 416,660 shares with a grant date exercise price per share of $600.00 and remaining contractual term of 7.4 years. As of September 30, 2023, the CEO Option Award had no intrinsic value. No other options have been granted under the CEO Incentive Plan. As of September 30, 2023, total unrecognized compensation cost related to options under the CEO Incentive Plan, net of estimated forfeitures, was $40.4 million and is expected to be recognized over a weighted-average remaining service period of 3.1 years. Valuation of Stock-Awards No options were issued under the 2021 Plan or the CEO Incentive Plan in the nine months ended September 30, 2023 and 2022. The grant date fair value for Other RSUs issued under the 2021 Plan in the nine months ended September 30, 2023 was calculated using the closing sale price of the Company’s Class A common stock on the grant date. Stock-based Compensation Expense The Company’s stock-based compensation included in its condensed consolidated statements of comprehensive loss was as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Cost of revenue $ 297 $ 418 $ 1,020 $ 1,126 Research and development 1,022 2,032 3,216 3,587 Selling, general, and administrative 9,291 20,776 28,326 54,122 Total $ 10,610 $ 23,226 $ 32,562 $ 58,835

Restructuring

Restructuring	9 Months Ended
	Sep. 30, 2023
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring In March 2023, the Company announced a restructuring plan to reduce structural costs, including its workforce. As a result of the restructuring plan, the Company recorded $4.2 million in restructuring costs during the three months ended March 31, 2023 for employee severance and other costs for employees impacted by the plan. The Company also recorded $1.3 million in restructuring costs during the three months ended June 30, 2023 primarily related to the relocation of certain long-lived assets associated with the Company’s R&D equipment from its headquarters in Milpitas, California to its manufacturing facility in Olive Branch, Mississippi. The Company incurred an immaterial amount of additional restructuring costs associated with the relocation of such R&D equipment during the three months ended September 30, 2023. During the three months ended September 30, 2023, the Company also recorded a $0.7 million reduction to the amount accrued for other costs for employees impacted by the restructuring plan announced in March 2023 due to a change in the estimate of such costs. No other restructuring charges were incurred during the nine months ended September 30, 2023. As of March 31, 2023, there were $4.2 million in restructuring cost related liabilities recorded in accrued compensation. $2.9 million and $0.6 million of the accrued restructuring costs related to compensation were paid during the second and third quarters of 2023, respectively. The Company also recorded a $0.7 million reduction to accrued compensation due to a change in the estimate of such costs and no additional restructuring costs were accrued as of September 30, 2023. As such, the total ending liability related to restructuring costs was $0.1 million as of September 30, 2023. The Company may incur additional costs in the future due to events that may occur as a result of, or that are associated with, the restructuring or other undetermined plans to reduce structural costs, such as the additional reduction in workforce disclosed further in Note 15 .

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company calculates the provision for income taxes during interim reporting periods by applying an estimate of the annual effective tax rate for the full fiscal year to ordinary income or loss for the interim reporting period. When applicable, the year-to-date tax provision reflects adjustments from discrete tax items. For the three and nine months ended September 30, 2023 and 2022, the Company’s income tax expense was immaterial. As the Company’s U.S. operations are projecting to be in a taxable loss in the year and based on all available objectively verifiable evidence during the nine months ended September 30, 2023, the Company believes it is more likely than not that the tax benefits of the U.S. losses incurred will not be realized. Accordingly, the Company will continue to maintain a full valuation allowance on the U.S. deferred tax assets. The Company’s income tax expense for the three and nine months ended September 30, 2023 is due primarily to income taxes for foreign operations. The Company accounts for the uncertainty in income taxes by utilizing a comprehensive model for the recognition, measurement, presentation, and disclosure in financial statements of any uncertain tax positions that have been taken or are expected to be taken on an income tax return. During the three and nine months ended September 30, 2023, there have been no changes in the estimated uncertain tax benefits.

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share data): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Net loss $ (213,046) $ (82,065) $ (336,695) $ (247,323) Weighted-average shares outstanding, basic and diluted 4,015,307 3,579,584 3,982,824 3,573,700 Net loss per share, basic and diluted $ (53.06) $ (22.93) $ (84.54) $ (69.21) For the three and nine months ended September 30, 2023, common stock equivalents consisted of stock options, restricted stock units, warrants, and the Convertible Notes. For the three and nine months ended September 30, 2022, common stock equivalents consisted of stock options, restricted stock units, and warrants. None of the common stock equivalents were included in the calculation of diluted net loss per share for all periods presented as the Company recorded a net loss. The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect: September 30, 2023 2022 Stock options to purchase common stock 385,750 402,002 Unvested restricted stock units 200,045 112,498 Warrants to purchase common stock 456,395 355,085 Convertible Notes (on an as-converted basis) 1,537,087 — Total 2,579,277 869,585 The 82,835 Sponsor Earn-Out Shares are excluded from basic and diluted net loss per share as such shares are contingently recallable until the share price of the Company exceeds specified thresholds that have not been achieved as of September 30, 2023. The common stock equivalents subject to the CEO Option Award are excluded from the anti-dilutive table as the underlying shares are contingently issuable until the share price of the Company exceeds the specified thresholds that have not been achieved. As of September 30, 2023 and 2022, the thresholds for the CEO Option Award have not been achieved, and 416,660 stock options for the CEO Option Award are outstanding. Prior to the Amendment described further in Note 10

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions The Purchasers of the Convertible Notes include affiliates of RXR FP, a party with which the Company has an existing commercial relationship and with which it has engaged in and continues to engage in corporate transactions. The Chairman and CEO of RXR FP was on the Company’s board of directors from November 2022 to October 2023. As such, RXR FP was identified as a related party during fiscal year 2022 and 2023. Convertible Notes, net of debt issuance costs, outstanding to RXR FP (the “RXR Notes”) as of September 30, 2023 and December 31, 2022 totaled $113.6 million and $109.1 million, respectively. Interest of $5.2 million and $2.0 million associated with the RXR Notes was accrued within other liabilities on the Consolidated Balance Sheet as of September 30, 2023 and December 31, 2022, respectively. The Company incurred $2.9 million and $8.3 million interest expense, inclusive of the amortization of debt issuance costs, on the RXR Notes during the three and nine months ended September 30, 2023, respectively. No interest expense was incurred on the RXR Notes during the three and nine months ended September 30, 2022, as the RXR Notes were issued in October 2022. The Company recognized revenue from RXR FP, or an agent acting on behalf of RXR FP, of $11.8 million and $1.4 million during the three months ended September 30, 2023 and 2022, respectively. The Company recognized revenue from RXR FP, or an agent acting on behalf of RXR FP, of $19.2 million and $4.9 million during the nine months ended September 30, 2023 and 2022, respectively. In addition, the Company had $5.6 million in deferred revenue, $4.6 million in contract loss accruals, $5.8 million contract assets associated with contracts with RXR FP, $10.9 million accounts receivable due from RXR FP or an agent acting on behalf of RXR FP, and no accounts payable due to RXR FP as of September 30, 2023. The Company had $4.2 million in deferred revenue, $8.7 million in contract loss accruals, no contract assets associated with contracts with RXR FP, $7.3 million accounts receivable due from RXR FP or an agent acting on behalf of RXR FP, and no accounts payable due to RXR FP as of December 31, 2022. As discussed in Note 9 , the Company issued the RXR Warrants to RXR FP on October 25, 2022. Refer to Note 9 for further information on the RXR Warrants.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined that, other than the events disclosed below, no additional material subsequent events exist. Credit Agreement On October 16, 2023, the Company entered into a new senior secured term loan credit agreement with Cantor Fitzgerald Securities, as administrative agent and as collateral agent, and the lenders party thereto (the “Credit Agreement”). The Credit Agreement establishes (i) a $12.5 million senior secured term loan facility and (ii) a $37.5 million senior secured delayed draw term loan facility, each maturing on September 30, 2027. Loans made under the term loan facility will bear interest at an annual rate equal to Term SOFR, plus (i) a margin of 7.50%, for interest paid in cash, or (ii) a margin of 14.0%, for interest paid in kind. In addition, the Company will pay an unused commitment fee in the amount equal to the annual rate of 3.75% times the daily unused portion of the revolving credit commitment. The unused commitment fee is payable quarterly in arrears. Upon closing of the Credit Agreement, the Company borrowed an initial $12.5 million, resulting in net proceeds of approximately $10 million, after deducting fees and estimated offering expenses. The Company’s ability to make the anticipated additional draws are subject to (i) a cap on the amount of draws that may be requested in any one calendar week of $2 million, (ii) with respect to any draw made after December 31, 2023, delivery of a budget approved by the lenders, (iii) no default or event of default continuing under the Credit Agreement, (iv) the representations and warranties set forth in the Credit Agreement and the related loan documentation being true and correct in all material respects, (v) the use of proceeds of any such draw not being in contravention with the then-current approved budget, (vi) the consummation of certain required post-closing requirements and (vii) liquidity of at least $25 million. If the Company is not able to secure sufficient financing and the audited financial statements for the fiscal year ending December 31, 2023 include a “going concern” qualification, this will result in an event of default under the Credit Agreement. Should an event of default occur, any available borrowings from the Credit Agreement would no longer be available and outstanding indebtedness under the Credit Agreement may become immediately due and payable. Mandatory prepayments of the term loan facility are required to be made upon the occurrence of certain events, including, without limitation, the incurrence of non-permitted indebtedness. Voluntary prepayments are permitted at any time, subject to certain prepayment premiums. The Credit Agreement contains a minimum cash balance covenant as well as customary affirmative and negative covenants, including limitations with respect to indebtedness, liens, investments, dividends, disposition of assets, change in business and transactions with affiliates. The Credit Agreement contains a subjective acceleration clause based on the lender determining, in the exercise of its reasonable discretion, that a “material adverse effect” in our business has occurred. If this clause is applied, and the lender declares that an event of default has occurred, the outstanding indebtedness under the Credit Agreement may become immediately due and payable. The Company intends to use the proceeds of the term loan facility for ordinary and necessary business expenses not inconsistent with the terms of the Credit Agreement. Restructuring On October 13, 2023, the Company decreased overall headcount by approximately 100 employees, which represented approximately 22% of full-time employees as of October 13, 2023. The reduction in workforce was substantially implemented in October 2023. The Company expects to incur a one-time charge of approximately $2.1 million in the fourth quarter of 2023 related to the restructuring plan, consisting primarily of one-time severance payments upon termination of the employees impacted by the reduction in force and continued benefits for a specific period of time with related cash payments expected to be substantially paid out by November 15, 2023. The Company expects such payments to be the only direct expense of the reduction in workforce. The Company does not expect to recognize a stock-based compensation expense for impacted employees related to vested awards and does not anticipate modifying the affected employees’ stock awards in a manner that would result in

Organization and Summary of S_2

Organization and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	View, Inc. and its wholly-owned subsidiaries (collectively “View” or the “Company”), headquartered in Milpitas, California, is a technology company that manufactures smart building products intended to help improve people’s health, productivity, and experience, while simultaneously reducing energy consumption. View’s primary product is a proprietary electrochromic or “smart” glass panel that when combined with View’s proprietary network infrastructure and software, intelligently adjusts in response to the sun by tinting from clear to dark states, and vice versa, thereby reducing heat and glare. The Company is devoting substantially all of its efforts towards the manufacturing, sale and further development of its product platforms, and marketing of both custom and standardized product solutions.
Basis of Presentation	The condensed consolidated financial statements and accompanying notes have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and regulations of the U.S. Securities and Exchange Commission (the “SEC”) for interim financial reporting and are unaudited. The Company’s condensed consolidated financial statements include the accounts of View, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company’s fiscal year ends on December 31. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2022, included in the Company’s 2022 Annual Report on Form 10-K filed with the SEC on March 31, 2023. The information as of December 31, 2022 included in the condensed consolidated balance sheets was derived from those audited consolidated financial statements. For the three and nine months ended September 30, 2023 and 2022, there was no difference between net loss and total comprehensive loss. The condensed consolidated financial statements were prepared on the same basis as the audited consolidated financial statements and included herein reflect all adjustments, including normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of the Company’s financial position as of September 30, 2023, the results of operations for the three and nine months ended September 30, 2023 and the cash flows for the nine months ended September 30, 2023. The results of operations for the three and nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected for the full year or any other future interim or annual periods. All amounts are presented in U.S. dollars ($).
Concentration of Credit Risk and Other Risks and Uncertainties	Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash and cash equivalents, restricted cash, and accounts receivable. Cash and cash equivalents are almost entirely held by domestic financial institutions with high credit standings. Such deposits may, at times, exceed federally insured limits. As of September 30, 2023, the Company has not experienced any losses on its deposits of cash and cash equivalents. For the nine months ended September 30, 2023, four customers represented greater than 10.0% of total revenue, accounting for 22.8%, 17.1%, 11.6% and 10.9% of total revenue, respectively. For the nine months ended September 30, 2022, two customers represented greater than 10.0% of total revenue, accounting for 16.2% and 15.5% of total revenue, respectively. Three customers accounted for 49.2% of accounts receivable, net as of September 30, 2023, accounting for 26.4%, 12.7% and 10.0%, respectively. Two customers accounted for 27.3% of accounts receivable, net as of December 31, 2022, accounting for 17.3% and 10.0%, respectively. Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition.
Segment Reporting	Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company operates and manages its business as one reportable and operating segment. The Company’s chief executive officer, who is the chief operating decision maker, reviews financial information on a consolidated basis for purposes of allocating resources and assessing performance.
Revenue Recognition	The Company disaggregates revenue between products and services, as well as by major product offering and by geographic market that depict the nature, amount, and timing of revenue and cash flows.View Smart Glass contracts to provide Controls, Software and Services (“CSS”) include the sale of both products and services. These services primarily relate to CSS installation and commissioning and are presented in the table above as Services. Also included within Services in the table above are revenues associated with extended or enhanced warranties. View Smart Glass contracts to provide insulating glass units (“IGUs”), View Smart Building Platform contracts and View Smart Building Technologies contracts relate to the sale of products. Remaining Performance Obligations The Company’s IGU contracts are short-term in nature and the practical expedient has been applied. The Company’s performance obligations in CSS contracts are generally short-term in nature, for which the practical expedient has been applied, with the exception of commissioning services, which are provided at the end of a construction project. Revenue for commissioning services performance obligations is not material. The Company’s performance obligations in Smart Building Platform contracts are longer-term in nature, however many of these contracts provide the customer with a right to cancel or terminate for convenience with no substantial penalty. The transaction price allocated to remaining performance obligations for non-cancelable Smart Building Platform contracts as of September 30, 2023 was $6.1 million that the Company expects to recognize as it satisfies the performance obligations over the next 12 to 24 months, which are, among other things, dependent on the construction schedule of the site for which the Company's products and services are provided. The Company’s performance obligations in Smart Building Technologies contracts are generally short-term in nature, for which the practical expedient has been applied. Contract Assets and Liabilities Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing, where payment is conditional, as well as retainage for amounts that the Company has billed to the customer but are being held for payment by the customer pending satisfactory completion of the project. Current contract assets as of September 30, 2023 and December 31, 2022 were $20.4 million and $14.6 million, respectively. The progress billing schedules for these contracts result in timing differences as compared to the Company’s satisfaction of its performance obligation. Non-current contract assets as of September 30, 2023 and December 31, 2022 were $1.2 million and $0.7 million, respectively, and were included in other assets. Contract liabilities relate to amounts invoiced or consideration received from customers, typically for the Company’s CSS contracts, in advance of the Company’s satisfaction of the associated performance obligation. Such contract liabilities are recognized as revenue when the performance obligation is satisfied. Contract liabilities are presented as deferred revenue on the condensed consolidated balance sheets.
Fair Value Measurement of Financial Assets and Liabilities	Sponsor Earn-out Shares, as defined below, and the Company’s privately placed warrants (“Private Warrants”) are subject to remeasurement to fair value at each balance sheet date. Changes in fair value as a result of the remeasurement are recognized in gain on fair value change, net in the condensed consolidated statements of comprehensive loss. Other The carrying amounts of cash equivalents relating to demand deposits and U.S. Treasury bills, accounts receivable, and accounts payable approximates fair value due to the short maturity of these instruments. The carrying amount of long-term trade receivables approximates fair value, which is estimated by discounting expected future cash flows using an average discount rate adjusted for the customer's creditworthiness. Short-term and long-term debt associated with the term loan are carried at amortized cost, which approximates its fair value. The Convertible Notes are carried at amortized cost and their fair value is determined using Level 3 inputs, as discussed further in Note 7 .
Short-term Investments	The Company’s marketable debt securities had contractual maturities of less than one year, were classified as available-for-sale and were stated at fair value on the consolidated balance sheets based upon inputs other than quoted prices in active markets (Level 2 inputs).
Accounts Receivable, Net of Allowances	The Company regularly reviews accounts receivable for collectability and establishes or adjusts the allowance for credit losses as necessary using the specific identification method based on the available facts.
Inventories	Inventories consist of finished goods which are stated at the lower of cost or net realizable value. Costs are measured on a first-in, first out basis using standard cost, which approximates actual cost. Net realizable value is the estimated selling price of the Company’s products in the ordinary course of business less reasonably predictable costs of completion, disposal, and transportation. Inventories are written down to their net realizable value if they have become obsolete, have a cost basis in excess of expected net realizable value, or are in excess of expected demand. Once inventory is written down, its new value is maintained until it is sold, scrapped, or written down for further valuation losses. The valuation of inventories requires the Company to make judgments based on currently available information about the likely method of disposition and current and future product demand relative to the remaining product life. Inventory valuation losses are classified as cost of revenue in the condensed consolidated statements of comprehensive loss.

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Summary of Company's Revenue	The following table summarizes the Company’s revenue by products and services (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue: Products $ 37,131 $ 21,548 $ 82,640 $ 52,461 Services 1,089 2,214 1,962 4,629 Total $ 38,220 $ 23,762 $ 84,602 $ 57,090 The following table summarizes the Company's revenue by major product offering (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue: Smart Building Platform $ 25,031 $ 11,317 $ 53,688 $ 29,578 Smart Glass 11,156 10,320 23,529 19,809 Smart Building Technologies 2,033 2,125 7,385 7,703 Total $ 38,220 $ 23,762 $ 84,602 $ 57,090 The following table summarizes the Company’s revenue by geographic area, which is based on the shipping addresses of the customers (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue: United States $ 37,500 $ 21,743 $ 80,470 $ 52,852 Canada 720 2,009 4,132 4,170 Other — 10 — 68 Total $ 38,220 $ 23,762 $ 84,602 $ 57,090

Fair Value (Tables)

Fair Value (Tables)	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Summary of Fair Value Measurements	The following table presents information about the Company’s financial assets and liabilities measured at fair value on a recurring basis (in thousands): September 30, 2023 Level 1 Level 2 Total Cash equivalents: Money market funds $ 32,315 $ — $ 32,315 Restricted cash: Certificates of deposit — 14,726 14,726 Total assets measured at fair value $ 32,315 $ 14,726 $ 47,041 December 31, 2022 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 66,614 $ — $ — $ 66,614 Restricted cash: Certificates of deposit — 18,308 — 18,308 Short-term investments — 102,284 — 102,284 Total assets measured at fair value $ 66,614 $ 120,592 $ — $ 187,206 Sponsor earn-out liability $ — $ — $ 506 $ 506 Private warrants liability — — 7 7 Total liabilities measured at fair value $ — $ — $ 513 $ 513
Summary of Level 3 Financial Liabilities Measured at Fair Value Using Significant Unobservable Inputs	The following table provides a reconciliation of the beginning and ending balances for the level 3 financial liabilities measured at fair value using significant unobservable inputs (in thousands): Sponsor Private Balance as of December 31, 2022 $ 506 $ 7 Change in fair value (506) (7) Balance as of September 30, 2023 $ — $ —
Summary of Gain (Loss) in Fair Value	The following table summarizes the gain on fair value change, net (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Sponsor Earn-out Liability $ — $ (225) $ (506) $ (6,364) Private Warrants — (1) (7) (147) Gain on fair value change, net $ — $ (226) $ (513) $ (6,511)
Summary of Assumptions Used in Determination of Fair Value of Derivatives	The estimated fair value of the Sponsor Earn-Out Shares of $0.0 million and $0.5 million as of September 30, 2023 and December 31, 2022, respectively, was determined using a Monte Carlo simulation valuation model using the following assumptions: September 30, 2023 December 31, 2022 Stock price $7.51 $57.90 Expected volatility 64.25% 69.25% Risk free rate 4.90% 4.22% Expected term (in years) 2.4 3.2 Expected dividends 0% 0% The estimated fair value of the Private Warrants of $0.0 million as of both September 30, 2023 and December 31, 2022, was determined using the Black-Scholes option-pricing model using the following assumptions: September 30, 2023 December 31, 2022 Stock price $7.51 $57.90 Expected volatility 64.25% 69.25% Risk free rate 5.07% 4.32% Expected term (in years) 1.9 2.7 Expected dividends 0% 0%

Other Balance Sheet Informati_2

Other Balance Sheet Information (Tables)	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Restrictions on Cash and Cash Equivalents	Cash, cash equivalents, and restricted cash reported within the accompanying condensed consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying condensed consolidated statements of cash flows consisted of the following (in thousands): September 30, 2023 December 31, 2022 Cash $ 18,303 $ 29,244 Cash equivalents 32,315 66,614 Cash and cash equivalents 50,618 95,858 Short-term restricted cash 14,000 1,859 Restricted cash 726 16,448 Total cash, cash equivalents, and restricted cash presented in the statements of cash flows $ 65,344 $ 114,165
Schedule of Cash and Cash Equivalents	Cash, cash equivalents, and restricted cash reported within the accompanying condensed consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying condensed consolidated statements of cash flows consisted of the following (in thousands): September 30, 2023 December 31, 2022 Cash $ 18,303 $ 29,244 Cash equivalents 32,315 66,614 Cash and cash equivalents 50,618 95,858 Short-term restricted cash 14,000 1,859 Restricted cash 726 16,448 Total cash, cash equivalents, and restricted cash presented in the statements of cash flows $ 65,344 $ 114,165
Investment	Short-term investments as of December 31, 2022 consisted of the following: Amortized Cost Unrealized Gain/(Loss) Fair Value Commercial Paper $ 59,684 $ — $ 59,684 Corporate Notes/Bonds 4,914 — 4,914 U.S. Treasuries 31,804 — 31,804 U.S. Government Agencies 5,882 — 5,882 Total short-term investments $ 102,284 $ — $ 102,284
Schedule of Accrued Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): September 30, 2023 December 31, 2022 Warranty accrual ( Note 5 ) $ 13,945 $ 10,236 Contract loss accrual ( Note 2 ) 6,842 12,848 Environmental settlement accrual ( Note 6 ) 1,000 1,450 Lease liability 3,733 3,949 Subcontractor accrual 16,312 18,435 Other 15,377 25,492 Accrued expenses and other current liabilities $ 57,209 $ 72,410

Product Warranties (Tables)

Product Warranties (Tables)	9 Months Ended
	Sep. 30, 2023
Guarantees and Product Warranties [Abstract]
Schedule of Product Warranty Liability	Changes in warranty liabilities are presented below (in thousands): September 30, 2023 December 31, 2022 Beginning balance $ 39,573 $ 42,256 Accruals for warranties issued 1,682 1,626 Changes to estimates of volume and costs 3,991 2,004 Settlements made (4,312) (6,313) Ending balance $ 40,934 $ 39,573 Warranty liability, current, beginning balance $ 10,236 $ 8,868 Warranty liability, noncurrent, beginning balance $ 29,337 $ 33,388 Warranty liability, current, ending balance $ 13,945 $ 10,236 Warranty liability, noncurrent, ending balance $ 26,989 $ 29,337

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Litigation Settlement Liability	The balances of the litigation settlement liability are recorded in accrued expenses and other current liabilities and other liabilities, respectively, on the Company’s condensed consolidated balance sheets as follows (in thousands): September 30, 2023 December 31, 2022 Litigation settlement liability - current $ 3,000 $ 3,000 Litigation settlement liability - non-current 3,332 5,794 Total litigation settlement liability $ 6,332 $ 8,794 The balances of the environmental settlement liability are recorded in accrued expenses and other current liabilities and other liabilities, respectively, on the Company’s condensed consolidated balance sheets as follows (in thousands): September 30, 2023 December 31, 2022 Environmental settlement liability - current $ 1,000 $ 1,450 Environmental settlement liability - non-current 1,000 3,000 Total environmental settlement liability $ 2,000 $ 4,450

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Summary of Debt	Debt outstanding consisted of the following (in thousands): September 30, 2023 December 31, 2022 Convertible Notes, net of debt issuance costs $ 196,576 $ 206,347 Term loan 13,225 13,960 Total debt 209,801 220,307 Debt, current 1,470 1,470 Debt, non-current $ 208,331 $ 218,837
Schedule of Estimated Principal Payments on all Debt Outstanding	Principal payments on all debt outstanding as of September 30, 2023 are estimated as follows (in thousands): Year Ending December 31, Total 2023 (remaining three months) $ 735 2024 1,470 2025 1,470 2026 1,470 2027 198,046 Thereafter 6,610 Total $ 209,801
Convertible Debt	The following tables present the Company’s convertible debt outstanding (in thousands): September 30, 2023 Gross amount Debt discount and issuance costs Carrying amount Estimated fair value Convertible Notes $ 201,607 $ (5,031) $ 196,576 $ 111,627 December 31, 2022 Gross amount Debt discount and issuance costs Carrying amount Estimated fair value Convertible Notes $ 212,308 $ (5,961) $ 206,347 $ 199,163 The following table presents the Company’s interest expense related to convertible debt (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Contractual interest expense $ 4,536 $ — $ 13,409 $ — Amortization of debt discount and issuance costs 295 — 719 — Total interest expense $ 4,831 $ — $ 14,128 $ —

Stock Warrants (Tables)

Stock Warrants (Tables)	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Summary of Outstanding Common Stock Warrants	The following table summarizes the outstanding common stock warrants: Warrant issue date Types of shares issued Number of Warrants September 30, 2023 Number of Warrants December 31, 2022 Exercise Price Per Warrant Expiry Date August 2010 - June 2011 Common stock — 774 $ 929.40 March 2023 August 2011 - January 2012 Common stock — 887 1,126.80 March 2023 August 2012 Common stock — 756 1,296.00 March 2023 December 2013 Common stock — 1,054 1,554.60 March 2023 April 2016 - November 2018 Common stock 18,923 18,923 1,135.80 Through November 2028 March 2017 Common stock 30,823 30,823 774.60 March 2027 March 2014 Common stock — 38 568.20 August 2023 December 2018 Common stock 415 415 542.40 December 2028 August 2020 Common stock (Private Warrants) 6,111 6,111 690.00 Through March 2026 August 2020 Common stock (Public Warrants) 277,777 277,777 690.00 Through March 2026 December 2021 Common stock (in connection with the WorxWell acquisition) 16,666 16,666 600.00 December 2031 October 2022 Common stock (in connection with the Strategic Agreement with RXR FP) 158,518 158,518 $ 0.60 October 2032 Total stock warrants 509,233 512,742

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Summary of Stock Options Exercisable under CEO Incentive Plan	Tranche Option Shares (#) Average 60-day 1 41,666 $ 1,200.00 2 41,666 1,800.00 3 41,666 2,400.00 4 41,666 3,000.00 5 41,666 3,600.00 6 41,666 4,200.00 7 41,666 4,800.00 8 41,666 5,400.00 9 41,666 6,000.00 10 41,666 $ 6,600.00
Summary of Share-based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable	The following table summarizes the activity under the 2021 Plan for time vested options: Options Outstanding Number of Weighted- Weighted-Average Aggregate Intrinsic Value 1 Balance as of December 31, 2022 400 $ 567.23 6.0 $ — Granted — — Exercised — — Canceled/forfeited (15) 588.42 Outstanding as of September 30, 2023 385 $ 566.06 5.4 $ — Options vested and expected to vest as of September 30, 2023 386 $ 566.07 5.4 $ — Exercisable as of September 30, 2023 365 $ 564.20 5.2 $ — _______________________
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The following table summarizes the activities for the outstanding RSUs under the 2021 Plan during the nine months ended September 30, 2023: Number of Weighted Average Grant Date Fair Value 1 Outstanding as of December 31, 2022 254 $ 240.00 Granted 106 32.89 Vested (131) 170.29 Canceled (30) 69.25 Outstanding as of September 30, 2023 199 $ 201.31
Summary of Stock-based Compensation	The Company’s stock-based compensation included in its condensed consolidated statements of comprehensive loss was as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Cost of revenue $ 297 $ 418 $ 1,020 $ 1,126 Research and development 1,022 2,032 3,216 3,587 Selling, general, and administrative 9,291 20,776 28,326 54,122 Total $ 10,610 $ 23,226 $ 32,562 $ 58,835

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Summary of Basic and Diluted Net Loss Per Share	The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share data): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Net loss $ (213,046) $ (82,065) $ (336,695) $ (247,323) Weighted-average shares outstanding, basic and diluted 4,015,307 3,579,584 3,982,824 3,573,700 Net loss per share, basic and diluted $ (53.06) $ (22.93) $ (84.54) $ (69.21)
Summary of Antidilutive Securities Excluded From Computation of Earnings Per Share	The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect: September 30, 2023 2022 Stock options to purchase common stock 385,750 402,002 Unvested restricted stock units 200,045 112,498 Warrants to purchase common stock 456,395 355,085 Convertible Notes (on an as-converted basis) 1,537,087 — Total 2,579,277 869,585

Organization and Summary of S_3

Organization and Summary of Significant Accounting Policies - Liquidity and Going Concern (Details) - USD ($)		3 Months Ended						9 Months Ended
	Oct. 16, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Product Information [Line Items]
Total stockholders’ deficit		$ 67,938,000	$ (134,869,000)	$ (180,992,000)	$ (287,774,000)	$ (349,689,000)	$ (414,434,000)	$ 67,938,000	$ (287,774,000)	$ (220,492,000)	$ (479,338,000)
Net loss		213,046,000	56,360,000	67,289,000	82,065,000	82,886,000	82,372,000	336,695,000	247,323,000
Negative cash flows from operations								139,603,000	204,201,000
Cash and cash equivalents		50,618,000						50,618,000		95,858,000
Credit Agreement | Line of Credit | Subsequent Event | Secured Debt
Product Information [Line Items]
Initial net proceeds	$ 10,000,000
Debt instrument face amount	12,500,000
Maximum weekly borrowing capacity	2,000,000
Covenant, liquidity, minimum	25,000,000
Credit Agreement, Delayed Draw | Line of Credit | Subsequent Event | Secured Debt
Product Information [Line Items]
Debt instrument face amount	$ 37,500,000
Accumulated Deficit
Product Information [Line Items]
Total stockholders’ deficit		2,931,115,000	2,718,069,000	2,661,709,000	2,504,654,000	2,422,589,000	2,339,703,000	$ 2,931,115,000	$ 2,504,654,000	$ 2,594,420,000	$ 2,257,331,000
Net loss		$ 213,046,000	$ 56,360,000	$ 67,289,000	$ 82,065,000	$ 82,886,000	$ 82,372,000

Organization and Summary of S_4

Organization and Summary of Significant Accounting Policies - Concentration Risk (Details)	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Cost of Goods and Service Benchmark | Supplier Concentration Risk | Supplier One
Concentration Risk [Line Items]
Concentration risk percentage	23.20%	26.70%
Cost of Goods and Service Benchmark | Supplier Concentration Risk | Supplier Two
Concentration Risk [Line Items]
Concentration risk percentage	21.90%	12.90%
Cost of Goods and Service Benchmark | Supplier Concentration Risk | Supplier Three
Concentration Risk [Line Items]
Concentration risk percentage	20.50%	11.20%
Cost of Goods and Service Benchmark | Supplier Concentration Risk | Supplier Four
Concentration Risk [Line Items]
Concentration risk percentage		10.10%
Customer One | Revenue from Contract with Customer Benchmark | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	22.80%	16.20%
Customer One | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	26.40%		17.30%
Customer Two | Revenue from Contract with Customer Benchmark | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	17.10%	15.50%
Customer Two | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	12.70%		10%
Customer Three | Revenue from Contract with Customer Benchmark | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	11.60%
Customer Three | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	10%
Customer Four | Revenue from Contract with Customer Benchmark | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	10.90%
Three Customer | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	49.20%
Two Customers | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage			27.30%

Organization and Summary of S_5

Organization and Summary of Significant Accounting Policies - Segment Reporting (Details)	9 Months Ended
	Sep. 30, 2023 segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of reportable segments	1
Number of operating segments	1

Organization and Summary of S_6

Organization and Summary of Significant Accounting Policies - Reverse Stock Split (Details)	Jul. 26, 2023	Jul. 25, 2023
Disaggregation of Revenue [Line Items]
Reverse stock split, conversion ratio	0.0167
Reverse Stock Split, Option One
Disaggregation of Revenue [Line Items]
Reverse stock split, conversion ratio		0.025
Reverse Stock Split, Option Two
Disaggregation of Revenue [Line Items]
Reverse stock split, conversion ratio		0.0222
Reverse Stock Split, Option Three
Disaggregation of Revenue [Line Items]
Reverse stock split, conversion ratio		0.02
Reverse Stock Split, Option Four
Disaggregation of Revenue [Line Items]
Reverse stock split, conversion ratio		0.0182
Reverse Stock Split, Option Five
Disaggregation of Revenue [Line Items]
Reverse stock split, conversion ratio		0.0167

Revenue - Summary of Company's

Revenue - Summary of Company's Revenue by Products and Services (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 38,220	$ 23,762	$ 84,602	$ 57,090
Products
Disaggregation of Revenue [Line Items]
Revenue	37,131	21,548	82,640	52,461
Services
Disaggregation of Revenue [Line Items]
Revenue	1,089	2,214	1,962	4,629
Smart Building Platform
Disaggregation of Revenue [Line Items]
Revenue	25,031	11,317	53,688	29,578
Smart Glass
Disaggregation of Revenue [Line Items]
Revenue	11,156	10,320	23,529	19,809
Smart Building Technologies
Disaggregation of Revenue [Line Items]
Revenue	$ 2,033	$ 2,125	$ 7,385	$ 7,703

Revenue - Summary of Company'_2

Revenue - Summary of Company's Revenue by Geographic Area (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 38,220	$ 23,762	$ 84,602	$ 57,090
United States
Disaggregation of Revenue [Line Items]
Revenue	37,500	21,743	80,470	52,852
Canada
Disaggregation of Revenue [Line Items]
Revenue	720	2,009	4,132	4,170
Other
Disaggregation of Revenue [Line Items]
Revenue	$ 0	$ 10	$ 0	$ 68

Revenue - Additional Informatio

Revenue - Additional Information (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Contract loss accrual	$ 200,000	$ 1,500,000	$ 1,800,000	$ 4,000,000
Contract loss accrual recognized	5,300,000	4,200,000	13,500,000	12,300,000
Catch-up adjustment to revenue	0	600,000	(3,800,000)	1,400,000
Contract losses for work not completed	7,100,000		7,100,000		$ 15,000,000
Current contract assets	20,384,000		20,384,000		14,587,000
Noncurrent contract assets	1,200,000		1,200,000		$ 700,000
Contract with customer liability revenue recognized	2,100,000	$ 1,300,000	6,300,000	$ 5,500,000
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Disaggregation of Revenue [Line Items]
Transaction price allocated to remaining performance obligation	$ 6,100,000		$ 6,100,000
Minimum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Disaggregation of Revenue [Line Items]
Revenue recognize period	12 months		12 months
Maximum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Disaggregation of Revenue [Line Items]
Revenue recognize period	24 months		24 months

Fair Value - Summary of Fair Va

Fair Value - Summary of Fair Value Measurements (Detail) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Cash equivalents:
Cash equivalents	$ 32,315,000	$ 66,614,000
Restricted cash:
Certificates of deposit	14,726,000	18,308,000
Short-term investments	0	102,284,000
Total assets measured at fair value	47,041,000	187,206,000
Sponsor earn-out liability		506,000
Private warrants liability		7,000
Total liabilities measured at fair value		513,000
Level 1
Cash equivalents:
Cash equivalents	32,315,000	66,614,000
Restricted cash:
Certificates of deposit	0	0
Short-term investments		0
Total assets measured at fair value	32,315,000	66,614,000
Sponsor earn-out liability		0
Private warrants liability		0
Total liabilities measured at fair value		0
Level 2
Cash equivalents:
Cash equivalents	0	0
Restricted cash:
Certificates of deposit	14,726,000	18,308,000
Short-term investments		102,284,000
Total assets measured at fair value	$ 14,726,000	120,592,000
Sponsor earn-out liability		0
Private warrants liability		0
Total liabilities measured at fair value		0
Level 3
Cash equivalents:
Cash equivalents		0
Restricted cash:
Certificates of deposit		0
Short-term investments		0
Total assets measured at fair value		0
Sponsor earn-out liability		506,000
Private warrants liability		7,000
Total liabilities measured at fair value		$ 513,000

Fair Value - Additional Informa

Fair Value - Additional Information (Detail)	Mar. 08, 2021 $ / shares shares	Sep. 30, 2023 $ / shares shares	Dec. 31, 2022 $ / shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn out shares subject to vesting and potential forfeiture (in shares) | shares	82,835	82,835
Share price (in dollars per share)		$ 7.51	$ 57.90
Earnout Triggering Event One
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Percentage of the earnout shares releasable	50%
Share price (in dollars per share)	$ 750
Number of trading days	5 days
Number of consecutive trading days	10 days
Terminating initial public offering term	5 years
Earnout Triggering Event Two
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Percentage of the earnout shares releasable	25%
Share price (in dollars per share)	$ 900
Number of trading days	5 days
Number of consecutive trading days	10 days
Earnout Triggering Event Three
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Percentage of the earnout shares releasable	25%
Share price (in dollars per share)	$ 1,200
Number of trading days	5 days
Number of consecutive trading days	10 days
Expected dividends | Sponsor Earn-Out Liability
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0	0

Fair Value - Summary of Level 3

Fair Value - Summary of Level 3 Financial Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2023 USD ($)
Sponsor Earn-Out Liability
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 506
Change in fair value	(506)
Ending balance	0
Private Warrants
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	7
Change in fair value	(7)
Ending balance	$ 0

Fair Value - Changes In Fair Va

Fair Value - Changes In Fair Value (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Gain on fair value change, net	$ 0	$ (226)	$ (513)	$ (6,511)
Sponsor Earn-Out Liability
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Gain on fair value change, net	0	(225)	(506)	(6,364)
Private Warrants | Warrants to purchase common stock
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Gain on fair value change, net	$ 0	$ (1)	$ (7)	$ (147)

Fair Value - Summary of Assumpt

Fair Value - Summary of Assumptions Used in Determination of Fair Value of Derivatives (Detail)	Sep. 30, 2023	Dec. 31, 2022
Sponsor Earn-Out Liability | Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	7.51	57.90
Sponsor Earn-Out Liability | Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.6425	0.6925
Sponsor Earn-Out Liability | Risk free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0490	0.0422
Sponsor Earn-Out Liability | Expected term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	2.4	3.2
Sponsor Earn-Out Liability | Expected dividends
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0	0
Private Warrants | Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	7.51	57.90
Private Warrants | Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.6425	0.6925
Private Warrants | Risk free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0507	0.0432
Private Warrants | Expected term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	1.9	2.7
Private Warrants | Expected dividends
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0	0

Other Balance Sheet Informati_3

Other Balance Sheet Information - Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash	$ 18,303	$ 29,244
Cash equivalents	32,315	66,614
Cash and cash equivalents	50,618	95,858
Short-term restricted cash	14,000	1,859
Restricted cash	726	16,448
Total cash, cash equivalents, and restricted cash presented in the statements of cash flows	$ 65,344	$ 114,165	$ 69,575	$ 297,543

Other Balance Sheet Informati_4

Other Balance Sheet Information - Schedule of Short Term Investments (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022
Cash and Cash Equivalents [Line Items]
Amortized Cost		$ 102,284,000
Unrealized Gain/(Loss)	$ 0	0	$ 0
Fair Value	$ 0	102,284,000
Commercial Paper
Cash and Cash Equivalents [Line Items]
Amortized Cost		59,684,000
Unrealized Gain/(Loss)		0
Fair Value		59,684,000
Corporate Notes/Bonds
Cash and Cash Equivalents [Line Items]
Amortized Cost		4,914,000
Unrealized Gain/(Loss)		0
Fair Value		4,914,000
U.S. Treasuries
Cash and Cash Equivalents [Line Items]
Amortized Cost		31,804,000
Unrealized Gain/(Loss)		0
Fair Value		31,804,000
U.S. Government Agencies
Cash and Cash Equivalents [Line Items]
Amortized Cost		5,882,000
Unrealized Gain/(Loss)		0
Fair Value		$ 5,882,000

Other Balance Sheet Informati_5

Other Balance Sheet Information - Additional Information (Details) - USD ($)	1 Months Ended	3 Months Ended			9 Months Ended
	Jun. 30, 2021	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Mar. 31, 2023	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unrealized Gain/(Loss)		$ 0		$ 0	$ 0	$ 0		$ 0
Credit-related impairment losses		0		0	0	0
Allowance for credit losses		0			0			0
Accrued interest receivable								700,000
Increase in allowance for credit losses		700,000			700,000
Allowance for doubtful accounts		1,800,000			1,800,000			1,100,000
Inventory write-down					8,400,000	14,200,000
Non-cancelable commitment, non-interest bearing period	31 months
Impairment of long-lived assets		0	$ 4,000,000
Non-cancelable commitment to purchase certain license subscriptions, interest rate after maturity	3.50%
Amount drawn against promissory note		6,000,000			6,000,000			6,999,000
Long-term debt		209,801,000			209,801,000			220,307,000
Shareholders' equity		(67,938,000)	$ 134,869,000	$ 287,774,000	(67,938,000)	$ 287,774,000	$ 180,992,000	220,492,000	$ 349,689,000	$ 414,434,000	$ 479,338,000
Impairment of long-lived assets (Note 4)		170,000,000			170,000,000
Estimate of Fair Value Measurement
Accounts, Notes, Loans and Financing Receivable [Line Items]
Shareholders' equity		17,000,000			17,000,000
Reported Value Measurement
Accounts, Notes, Loans and Financing Receivable [Line Items]
Shareholders' equity		102,000,000			102,000,000
Convertible Debt
Accounts, Notes, Loans and Financing Receivable [Line Items]
Estimated fair value		111,627,000			111,627,000			199,163,000
Long-term debt		196,576,000			196,576,000			206,347,000
Term loan
Accounts, Notes, Loans and Financing Receivable [Line Items]
Long-term debt		$ 13,225,000			$ 13,225,000			$ 13,960,000
Unfunded Loan Commitment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-cancelable commitment to purchase certain license subscriptions	$ 10,000,000

Other Balance Sheet Informati_6

Other Balance Sheet Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Warranty accrual (Note 5)	$ 13,945	$ 10,236
Contract loss accrual (Note 2)	6,842	12,848
Environmental settlement liability - current	1,000	1,450
Lease liability	3,733	3,949
Subcontractor accrual	16,312	18,435
Other	15,377	25,492
Accrued expenses and other current liabilities	$ 57,209	$ 72,410

Product Warranties - Schedule o

Product Warranties - Schedule of Product Warranties (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Movement in Standard Product Warranty Accrual [Roll Forward]
Beginning balance	$ 39,573	$ 42,256
Accruals for warranties issued	1,682	1,626
Changes to estimates of volume and costs	3,991	2,004
Settlements made	(4,312)	(6,313)
Ending balance	40,934	39,573
Warranty liability, current, beginning balance	10,236	8,868
Warranty liability, current, ending balance	13,945	10,236
Warranty liability, noncurrent, beginning balance	29,337	33,388
Warranty liability, noncurrent, ending balance	$ 26,989	$ 29,337

Product Warranties - Additional

Product Warranties - Additional Information (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Product Warranty Liability [Line Items]
Warranty liability	$ 40,934	$ 39,573	$ 42,256
Accrued expenses and other current liabilities
Product Warranty Liability [Line Items]
Warranty liability	31,100	30,800
IGU
Product Warranty Liability [Line Items]
Warranty liability	$ 9,800	$ 8,800

Commitments and Contingencies -

Commitments and Contingencies - Standby Letter of Credit (Details) - Standby Letter of Credit - USD ($)	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Short-Term Debt [Line Items]
Total value of letters of credit issued by bank	$ 13,800,000	$ 15,700,000
Amounts drawn under standby letters of credit	$ 1,000,000

Commitments and Contingencies_2

Commitments and Contingencies - Litigation and Environmental Settlements (Details) - USD ($) $ in Millions	1 Months Ended
	Aug. 31, 2023	Dec. 31, 2014
Other Commitments [Line Items]
Litigation settlement, payment made to third party		$ 32
Periodic payment term		10 years
Northern District of Mississippi Environmental Matter
Other Commitments [Line Items]
Agree to probation years	3 years
Northern District of Mississippi Environmental Matter | Wastewater Reduction Plan Implementation
Other Commitments [Line Items]
Loss contingency, loss in period	$ 4.8
Northern District of Mississippi Environmental Matter | Federal Government
Other Commitments [Line Items]
Litigation settlement, amount due to third-party	$ 3
Litigation settlement, repayment period	3 years
Yearly installment amount	$ 1
Northern District of Mississippi Environmental Matter | Mississippi Commission On Environmental Quality
Other Commitments [Line Items]
Litigation settlement, amount due to third-party	1.5
Northern District of Mississippi Environmental Matter | Desoto County Regional Utility Authority
Other Commitments [Line Items]
Litigation settlement, amount due to third-party	$ 0.5

Commitments and Contingencies_3

Commitments and Contingencies - Schedule of Litigation and Environmental Settlement Liability (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Litigation settlement liability - current	$ 3,000	$ 3,000
Litigation settlement liability - non-current	3,332	5,794
Total litigation settlement liability	6,332	8,794
Environmental settlement liability - current	1,000	1,450
Environmental settlement liability - non-current	1,000	3,000
Total environmental settlement liability	$ 2,000	$ 4,450

Debt - Summary of Debt (Detail)

Debt - Summary of Debt (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Total	$ 209,801	$ 220,307
Debt, current	1,470	1,470
Debt, non-current	208,331	218,837
Convertible Debt
Debt Instrument [Line Items]
Total	196,576	206,347
Term loan
Debt Instrument [Line Items]
Total	$ 13,225	$ 13,960

Debt - Schedule of Estimated Pr

Debt - Schedule of Estimated Principal Payments on all Debt Outstanding (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
2023 (remaining three months)	$ 735
2024	1,470
2025	1,470
2026	1,470
2027	198,046
Thereafter	6,610
Total	$ 209,801	$ 220,307

Debt - Convertible Debt (Detail

Debt - Convertible Debt (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Debt Instrument [Line Items]
Total	$ 209,801		$ 209,801		$ 220,307
Convertible Debt
Debt Instrument [Line Items]
Gross amount	201,607		201,607		212,308
Debt discount and issuance costs	(5,031)		(5,031)		(5,961)
Total	196,576		196,576		206,347
Estimated fair value	111,627		111,627		$ 199,163
Contractual interest expense	4,536	$ 0	13,409	$ 0
Amortization of debt discount and issuance costs	295	0	719	0
Total interest expense	$ 4,831	$ 0	$ 14,128	$ 0

Debt - Additional Information (

Debt - Additional Information (Detail)				3 Months Ended
	Jan. 12, 2023 USD ($) $ / shares shares	Oct. 26, 2022 USD ($) day $ / shares	Oct. 22, 2020 USD ($) day	Sep. 30, 2023 USD ($) $ / shares	Dec. 31, 2022 USD ($) $ / shares	Oct. 31, 2022 USD ($)	Mar. 09, 2021 $ / shares	Nov. 22, 2010 USD ($) day
Debt Instrument [Line Items]
Blocker Agreement, days of prior written notice required		61 days
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001		$ 0.0001	$ 0.0001		$ 0.0001
Number of days audited financials are to be delivered to lender | day			210
Convertible Debt | Unsecured Convertible Senior PIK Toggle Notes
Debt Instrument [Line Items]
Debt instrument face amount						$ 200,000,000
Option to sell additional amount		$ 40,000,000
Debt instruments, additional debt purchased					$ 12,300,000
Proceeds from issuance of debt					$ 206,300,000
Debt instrument, conversion ratio		0.0124611
Debt instrument, conversion price (in dollars per share) | $ / shares	$ 64.20	$ 80.25
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001
Debt instrument, threshold scheduled trading days | day		41
Debt instrument, threshold percentage of stock price trigger		150%
Debt instrument, threshold trading days | day		20
Debt instrument, threshold consecutive trading days | day		30
Debt instrument, redemption price percentage		100%
Convertible Debt, Ownership Percentage		25%
Effective interest rate percentage				9.82%
Accrued interest added to principal balance				$ 7,300,000
Debt conversion, converted instrument, amount	$ 18,000,000			$ 0
Debt conversion, converted instrument, shares issued (in shares) | shares	280,373
Term loan | Mississippi
Debt Instrument [Line Items]
Debt instrument face amount								$ 40,000,000
Number of semi-annual installments | day								24
Amended and restated term loan
Debt Instrument [Line Items]
Debt instrument semi annual payments			$ 700,000
Minimum | Convertible Debt | Unsecured Convertible Senior PIK Toggle Notes | Director
Debt Instrument [Line Items]
Interest Rate		6%
Maximum | Convertible Debt | Unsecured Convertible Senior PIK Toggle Notes | Director
Debt Instrument [Line Items]
Interest Rate		9%

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail)			3 Months Ended				5 Months Ended	9 Months Ended		14 Months Ended
	Jan. 12, 2023 USD ($) $ / shares shares	Aug. 08, 2022 USD ($) day	Sep. 30, 2023 USD ($) $ / shares shares	Jun. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Sep. 30, 2022 USD ($) shares	Dec. 31, 2022 USD ($) $ / shares shares	Sep. 30, 2023 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) shares	Sep. 30, 2023 $ / shares shares	Oct. 26, 2022 $ / shares	Mar. 09, 2021 $ / shares shares
Subsidiary, Sale of Stock [Line Items]
Common stock, shares authorized (in shares)			600,000,000				600,000,000	600,000,000		600,000,000		600,000,000
Common stock, par value (in dollars per share) | $ / shares			$ 0.0001				$ 0.0001	$ 0.0001		$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares issued (in shares)			4,053,580				3,695,598	4,053,580		4,053,580
Common stock, shares outstanding (in shares)			4,053,580				3,695,598	4,053,580		4,053,580
Preferred stock, shares authorized (in shares)												1,000,000
Preferred stock, par value (in dollars per share) | $ / shares												$ 0.0001
Preferred stock, shares issued (in shares)			0					0		0
Preferred stock, shares outstanding (in shares)			0					0		0
Shares withheld related to net share settlement of equity awards (in shares)			14,035					49,389
Shares withheld related to net share settlement of equity awards | $			$ 142,000	$ 293,000	$ 1,001,000	$ 3,076,000		$ 1,400,000	$ 3,100,000
Treasury Stock issued and outstanding (in shares)			0					0		0
Restricted Stock Units (RSUs)
Subsidiary, Sale of Stock [Line Items]
Number of shares vested (in shares)						31,452			31,452
Unsecured Convertible Senior PIK Toggle Notes | Convertible Debt
Subsidiary, Sale of Stock [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001
Debt conversion, converted instrument, amount | $	$ 18,000,000		$ 0
Debt instrument, conversion price (in dollars per share) | $ / shares	$ 64.20										$ 80.25
Debt conversion, converted instrument, shares issued (in shares)	280,373
CF Principal Investments, LLC And YA II PN, Ltd. | Private Placement
Subsidiary, Sale of Stock [Line Items]
Maximum issuing capacity | $		$ 100,000,000
Number of shares purchased										0
Agreement effective period		36 years
Purchase price of common stock, percent		97%
Percentage of ownership after transaction, threshold		20%
Maximum threshold of ownership percentage		19.99%
Value of shares issued, commitment fee | $							$ 1,300,000
Agreement terms, days after filing | day		3
Agreement termination cost or penalty | $		$ 0
Right to terminate agreement, prior written notice required		3 days
CF Principal Investments, LLC | Private Placement
Subsidiary, Sale of Stock [Line Items]
Maximum threshold of ownership percentage		9.99%
YA II PN, Ltd. | Private Placement
Subsidiary, Sale of Stock [Line Items]
Maximum threshold of ownership percentage		4.99%

Stock Warrants - Additional Inf

Stock Warrants - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions			3 Months Ended	9 Months Ended
	Oct. 25, 2022	Dec. 01, 2021	Sep. 30, 2023	Sep. 30, 2023	Dec. 31, 2022
Class of Warrant or Right [Line Items]
Class of warrants or rights number of securities called by each warrant or right (in shares)			1	1
Number of warrants (in shares)			509,233	509,233	512,742
Class of warrant or right exercised (in shares)			0	0
Number of securities called by warrants (in shares)	158,518		158,518	158,518
Term of warrants	10 years
Class of warrant or right expired (in shares)			38	3,509
Public and Private Warrant
Class of Warrant or Right [Line Items]
Class of warrants or rights exercise price of warrants or rights (in dollars per share)			$ 690	$ 690
Private Warrants
Class of Warrant or Right [Line Items]
Terminating initial public offering term				5 years
Private Warrants | August 2020
Class of Warrant or Right [Line Items]
Class of warrants or rights exercise price of warrants or rights (in dollars per share)			$ 690	$ 690
Number of warrants (in shares)			6,111	6,111	6,111
Public Warrants
Class of Warrant or Right [Line Items]
Terminating initial public offering term				5 years
Public Warrants | August 2020
Class of Warrant or Right [Line Items]
Class of warrants or rights exercise price of warrants or rights (in dollars per share)			$ 690	$ 690
Number of warrants (in shares)			277,777	277,777	277,777
Market Vested Warrant
Class of Warrant or Right [Line Items]
Grant date fair value of RSUs vested	$ 9.2
Common stock | WorxWell
Class of Warrant or Right [Line Items]
Class of warrant or right exercised (in shares)			0	0
Warrants issued in connection with acquisition (in shares)		16,666

Stock Warrants - Summary of Out

Stock Warrants - Summary of Outstanding Common Stock Warrants (Detail) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	509,233	512,742
August 2010 - June 2011
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	0	774
Exercise price per warrant (in dollars per share)	$ 929.40
August 2011 - January 2012
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	0	887
Exercise price per warrant (in dollars per share)	$ 1,126.8
August 2012
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	0	756
Exercise price per warrant (in dollars per share)	$ 1,296
December 2013
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	0	1,054
Exercise price per warrant (in dollars per share)	$ 1,554.6
April 2016 - November 2018
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	18,923	18,923
Exercise price per warrant (in dollars per share)	$ 1,135.8
March 2017
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	30,823	30,823
Exercise price per warrant (in dollars per share)	$ 774.60
March 2014
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	0	38
Exercise price per warrant (in dollars per share)	$ 568.20
December 2018
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	415	415
Exercise price per warrant (in dollars per share)	$ 542.40
August 2020 | Private Warrants
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	6,111	6,111
Exercise price per warrant (in dollars per share)	$ 690
August 2020 | Public Warrants
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	277,777	277,777
Exercise price per warrant (in dollars per share)	$ 690
December 2021
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	16,666	16,666
Exercise price per warrant (in dollars per share)	$ 600
October 2022
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	158,518	158,518
Exercise price per warrant (in dollars per share)	$ 0.60

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail) - USD ($)			3 Months Ended		9 Months Ended		12 Months Ended	31 Months Ended
	Aug. 05, 2022	Mar. 08, 2021	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares outstanding under previous equity incentive plan (in shares)			385,000		385,000		400,000	385,000
Grant date fair value of stock options vested					$ 3,800,000	$ 22,300,000
Share-based compensation expense			$ 10,610,000	$ 23,226,000	32,562,000	$ 58,835,000
Unrecognized compensation cost related to unvested stock options			$ 5,300,000		$ 5,300,000			$ 5,300,000
Weighted-average remaining service period					1 year 4 months 24 days
Options granted (in shares)					0
Weighted-average exercise price (in dollars per share)			$ 566.06		$ 566.06		$ 567.23	$ 566.06
Weighted-average remaining contractual term					5 years 4 months 24 days		6 years
Aggregate Intrinsic Value			$ 0		$ 0			$ 0
Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 7,900,000
Restricted Stock Units (RSUs) | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted (in shares)						112,498
2018 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares outstanding under previous equity incentive plan (in shares)		410,955
2018 Plan | Year One Vesting | Share-based Payment Arrangement, Option | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage		25%
2021 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for issuance (in shares)		977,198
Shares reserved for future issuance (in shares)			167,021		167,021			167,021
2021 Plan | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense	14,600,000
2021 Plan | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted (in shares)					106,000
2021 Plan | Restricted Stock Units (RSUs) | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		4 years
Shares granted (in shares)		208,333
Incremental compensation expense	$ 22,500,000
2021 Plan | Restricted Stock Units (RSUs) | Employees, Directors, And Officers
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted (in shares)								259,504
2021 Plan | Restricted Stock Units (RSUs) | Employees, Directors, And Officers | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost related to equity instruments other than options expected to be recognised over a weighted average service period	1 year
2021 Plan | Restricted Stock Units (RSUs) | Employees, Directors, And Officers | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost related to equity instruments other than options expected to be recognised over a weighted average service period	4 years
2021 Plan | Restricted Stock Units (RSUs) | Share Price Hurdle Achieved One | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Non-equity instruments granted		50%
Vesting, share price hurdle (in dollars per share)		$ 900
2021 Plan | Restricted Stock Units (RSUs) | Share Price Hurdle Achieved Two | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Non-equity instruments granted		50%
Vesting, share price hurdle (in dollars per share)		$ 1,200
2021 Plan | Share-based Payment Arrangement, Option | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		4 years
2021 Plan | Share-based Payment Arrangement, Option | Class A common stock, par value, $0.0001 per share | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for issuance (in shares)		83,333
2021 Plan | Year One Vesting | Share-based Payment Arrangement, Option | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		12 months
Award vesting percentage		25%
2021 Plan | Monthly Vesting | Restricted Stock Units (RSUs) | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		36 months
Award vesting percentage		75%
2021 Plan | Monthly Vesting | Share-based Payment Arrangement, Option | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		36 months
Award vesting percentage		75%
Equity Incentive Plan 2021, Modified | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense	$ 21,200,000
Compensation cost related to equity instruments other than options expected to be recognised over a weighted average service period	2 years 7 months 6 days
CEO Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options exercised under plan (in shares)					0	0
Unrecognized compensation cost related to unvested stock options			$ 40,400,000		$ 40,400,000			$ 40,400,000
Options granted (in shares)					416,660
Weighted-average exercise price (in dollars per share)			$ 600		$ 600			$ 600
Weighted-average remaining contractual term					7 years 4 months 24 days
Aggregate Intrinsic Value			$ 0		$ 0			$ 0
Weighted-average remaining service period, compensation expected to be recognized					3 years 1 month 6 days
CEO Incentive Plan | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option award exercise price (in dollars per share)		$ 600
CEO Incentive Plan | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant date fair value of RSUs vested					$ 22,200,000	$ 33,500,000
Unrecognized compensation cost related to Equity instruments other than options			$ 25,100,000		$ 25,100,000			$ 25,100,000
Compensation cost related to equity instruments other than options expected to be recognised over a weighted average service period					2 years

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Stock Options Exercisable under CEO Incentive Plan (Detail)	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option Shares	0
CEO Incentive Plan | Year One Vesting
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option Shares	41,666
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 1,200
CEO Incentive Plan | Monthly Vesting
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option Shares	41,666
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 1,800
CEO Incentive Plan | Share-based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option Shares	41,666
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 2,400
CEO Incentive Plan | Share-based Payment Arrangement Tranche Four
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option Shares	41,666
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 3,000
CEO Incentive Plan | Share-based Payment Arrangement Tranche Five
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option Shares	41,666
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 3,600
CEO Incentive Plan | Share-based Payment Arrangement Tranche Six
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option Shares	41,666
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 4,200
CEO Incentive Plan | Share-based Payment Arrangement Tranche Seven
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option Shares	41,666
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 4,800
CEO Incentive Plan | Share-based Payment Arrangement Tranche Eight
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option Shares	41,666
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 5,400
CEO Incentive Plan | Share-based Payment Arrangement Tranche Nine
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option Shares	41,666
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 6,000
CEO Incentive Plan | Share-based Payment Arrangement Tranche Ten
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option Shares	41,666
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 6,600

Stock-Based Compensation - Su_2

Stock-Based Compensation - Summary of Share-based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Number of Shares Subject to Stock Options Outstanding
Beginning balance (in shares)	400
Options granted (in shares)	0
Exercised (in shares)	0
Canceled/forfeited (in shares)	(15)
Ending balance (in shares)	385	400
Weighted- Average Exercise Price
Weighted-Average Exercise Price, Beginning balance (in dollars per share)	$ 567.23
Options granted (in dollars per share)	0
Exercised (in dollars per share)	0
Canceled/forfeited (in dollars per share)	588.42
Weighted-Average Exercise Price, Ending balance (in dollars per share)	$ 566.06	$ 567.23
Stock Options Additional Disclosures
Weighted-Average Remaining Contractual Term, Outstanding	5 years 4 months 24 days	6 years
Aggregate Intrinsic Value, Options	$ 0	$ 0
Options vested and expected to vest (in shares)	386
Weighted-Average Exercise Price, Options vested and expected to vest (in dollars per share)	$ 566.07
Weighted-Average Remaining Contractual Term, Options vested and expected to vest	5 years 4 months 24 days
Aggregate Intrinsic Value, Options vested and expected to vest	$ 0
Exercisable (in shares)	365
Weighted-Average Exercise Price, (in dollars per share)	$ 564.20
Weighted-Average Remaining Contractual Term, Exercisable	5 years 2 months 12 days
Aggregate Intrinsic Value	$ 0
Share price (in dollars per share)	$ 7.51	$ 57.90

Stock Based Compensation - Summ

Stock Based Compensation - Summary of Outstanding Restricted Stock Units (Detail) - Restricted Stock Units (RSUs) - $ / shares		3 Months Ended	9 Months Ended
	Mar. 08, 2021	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Number of Unvested Shares
Vested (in shares)		(31,452)		(31,452)
Officer
Number of Unvested Shares
Granted (in shares)				112,498
2021 Plan
Number of Unvested Shares
Beginning balance (in shares)			254,000
Granted (in shares)			106,000
Vested (in shares)			(131,000)
Canceled (in shares)			(30,000)
Ending balance (in shares)			199,000
Weighted Average Grant Date Fair Value
Beginning balance (in dollars per share)			$ 240
Granted (in dollars per share)			32.89
Vested (in dollars per share)			170.29
Canceled (in dollars per share)			69.25
Ending balance (in dollars per share)			$ 201.31
2021 Plan | Officer
Number of Unvested Shares
Granted (in shares)	208,333

Stock-Based Compensation - Su_3

Stock-Based Compensation - Summary of Stock-based Compensation (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 10,610	$ 23,226	$ 32,562	$ 58,835
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	297	418	1,020	1,126
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	1,022	2,032	3,216	3,587
Selling, general, and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 9,291	$ 20,776	$ 28,326	$ 54,122

Restructuring (Details)

Restructuring (Details) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Restructuring and Related Activities [Abstract]
Restructuring costs	$ (662)	$ 1,300	$ 4,200	$ 0	$ 4,845	$ 0
Payments for restructuring	600	$ 2,900
Restructuring cost related liabilities	$ 100				$ 100

Income Taxes (Detail)

Income Taxes (Detail) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Changes in estimated uncertain tax benefits	$ 0	$ 0

Net Loss Per Share - Summary of

Net Loss Per Share - Summary of Basic and Diluted Net Loss Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
Earnings Per Share [Abstract]
Net loss	$ (213,046)	$ (56,360)	$ (67,289)	$ (82,065)	$ (82,886)	$ (82,372)	$ (336,695)	$ (247,323)
Weighted-average shares outstanding, basic (in shares)	4,015,307			3,579,584			3,982,824	3,573,700
Weighted-average shares outstanding, diluted (in shares)	4,015,307			3,579,584			3,982,824	3,573,700
Net loss per share, basic (in shares)	$ (53.06)			$ (22.93)			$ (84.54)	$ (69.21)
Net loss per share, diluted (in shares)	$ (53.06)			$ (22.93)			$ (84.54)	$ (69.21)

Net Loss Per Share - Summary _2

Net Loss Per Share - Summary of Antidilutive Securities Excluded From Computation of Earnings Per Share (Detail) - shares	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	2,579,277	869,585
Stock options to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	385,750	402,002
Restricted Stock Units (RSUs)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	200,045	112,498
Warrants to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	456,395	355,085
Redeemable Convertible Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,537,087	0

Net Loss Per Share - Additional

Net Loss Per Share - Additional Information (Detail) - shares	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Mar. 08, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Earn out shares subject to vesting and potential forfeiture (in shares)	82,835		82,835
Options granted (in shares)	0
Antidilutive securities excluded from computation of earnings per share (in shares)	2,579,277	869,585
Restricted Stock Units (RSUs)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	200,045	112,498
Officer | Restricted Stock Units (RSUs)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	67,493
Non Qualified Stock Option Awards | Chief Executive Officer
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options granted (in shares)	416,660	416,660
Restricted Stock Units (RSUs) | Officer
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares granted (in shares)		112,498

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Related Party Transaction [Line Items]
Long-term debt	$ 209,801,000		$ 209,801,000		$ 220,307,000
Revenue	38,220,000	$ 23,762,000	84,602,000	$ 57,090,000
Deferred revenue	11,284,000		11,284,000		9,199,000
Contract loss accrual (Note 2)	6,842,000		6,842,000		12,848,000
Current contract assets	20,384,000		20,384,000		14,587,000
Accounts receivable, net of allowances	42,571,000		42,571,000		42,407,000
Accounts payable	10,232,000		10,232,000		21,099,000
Related Party
Related Party Transaction [Line Items]
Revenue	11,751,000	1,394,000	19,175,000	4,934,000
Related Party | Convertible Notes, Net Of Debt Issuance
Related Party Transaction [Line Items]
Deferred revenue	5,600,000		5,600,000		4,200,000
Contract loss accrual (Note 2)	4,600,000		4,600,000		8,700,000
Current contract assets	5,800,000		5,800,000		0
Accounts receivable, net of allowances	10,900,000		10,900,000		7,300,000
Accounts payable	0		0		0
Convertible Debt
Related Party Transaction [Line Items]
Long-term debt	196,576,000		196,576,000		206,347,000
Interest expense, debt	4,831,000	0	14,128,000	0
Convertible Debt | Director
Related Party Transaction [Line Items]
Long-term debt	113,600,000		113,600,000		109,100,000
Accrued interest due to related party, current	5,200,000		5,200,000		$ 2,000,000
Interest expense, debt	$ 2,900,000	$ 0	$ 8,300,000	$ 0

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event	Oct. 16, 2023 USD ($)	Oct. 13, 2023 USD ($) day
Subsequent Event [Line Items]
Number of positions eliminated, inception to date | day		100
Decrease in overall headcount as a percent		22%
Restructuring one-time charge		$ 2,100,000
Credit Agreement | Line of Credit | Secured Debt
Subsequent Event [Line Items]
Debt instrument face amount	$ 12,500,000
Initial net proceeds	10,000,000
Maximum weekly borrowing capacity	2,000,000
Covenant, liquidity, minimum	25,000,000
Credit Agreement, Delayed Draw | Line of Credit | Secured Debt
Subsequent Event [Line Items]
Debt instrument face amount	$ 37,500,000
Credit Agreement, Delayed Draw | Line of Credit | Secured Debt | Secured Overnight Financing Rate (SOFR)
Subsequent Event [Line Items]
Unused capacity, commitment fee percentage	3.75%
Credit Agreement, Delayed Draw | Line of Credit | Secured Debt | Secured Overnight Financing Rate (SOFR) | Minimum
Subsequent Event [Line Items]
Variable interest rate	7.50%
Credit Agreement, Delayed Draw | Line of Credit | Secured Debt | Secured Overnight Financing Rate (SOFR) | Maximum
Subsequent Event [Line Items]
Variable interest rate	14%